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Foreword from the Organisers
Dystonias are amongst the most common movement disorders. Botu-
linum toxin and deep brain stimulation have revolutionized their
therapy. There are, however, still considerable unmet therapeutic needs.
For this reason a series of conferences have been initiated on this
topic. Two congresses have already taken place, in 2010 and 2013.
Both received an extremely warm welcome from the medical and
scientific community. We were therefore very enthusiastic about
organising a third congress, from May 4th to 7th, 2016. Pre-meeting
satellite events included the Second International Conference on
Rehabilitation of Dystonia and the newly introduced First Interna-
tional Conference on Dystonia in Sports.
The intense three-and-a-half day program consisting of state-of-
the-art lectures, special lectures, workshops, industry symposia and a
busy industry exhibition this time lured more than 500 participants
from over 40 countries and all continents to Hannover. With a faculty
of more than 80 world-leading experts from neurology, neurosurgery,
neuropediatrics, neurogenetics, allied health professions and basic
sciences this was, once again, the leading congress on dystonia.
The following abstracts accompanied the posters presented at the
Congress. They cover a wide spectrum of interesting topics and give a
comprehensive overview of the latest research in dystonia.
Enjoy reading and stay with us to further develop this open plat-
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Clinical effects for cervical dystonia using a device
inducing hanger reflex - multicenter trial
Asahi T.1, Sato M.2, Nakamura T.2, Kon Y.2, Kajimoto H.2,
Oyama G.3, Hayashi A.4, Tanaka K.5, Nakane T.6, Takeshima T.7,
Fujii M.8
1Kanazawa Neurosurgical Hospital, Department of Neurosurgery,
Ishikawa, Japan, 2University of Electro-Communications,
Department of Informatics, Tokyo, Japan, 3Juntendo University,
Department of Neurology, Tokyo, Japan, 4Juntendo University
Urayasu Hospital, Department of Rehabilitation, Chiba, Japan,
5Saiseikai Matsuyama Hospital, Department of Neurosurgery, Ehime,
Japan, 6Nagasaki Kawatana Medical Center, Department
of Neurology, Nagasaki, Japan, 7Tominaga Hospital, Department
of Neurology, Osaka, Japan, 8Yamaguchi University, Department
of Neurosurgery, Yamaguchi, Japan
Background: When the head is encircled with a wire clothes hanger
and the unilateral fronto-temporal region is compressed, the head
rotates unexpectedly. As the mechanism is unclear, however, we have
temporarily named this phenomenon as the hanger reflex (HF). We
previously reported that a HR occurs in more than 90% of normal
subject, and experience a case wherein this phenomenon was applied
to treat cervical dystonia (CD).
Objectives: Investigate the clinical effects for CD using a device
induce HR by a multicenter clinical trial.
Methods: This study included totally 19 patients (12 men and 7
women) aged 23–86 years with rotational type of CD. An elliptical
device induce the HR was applied to each subject’s head. Patients
applied the device more than 30 min/day for 3 months. Severity score
(part 1) of Toronto western torticollis scale (TWSTRS) with and
without the device were evaluated before and after 3 months trial.
Results: Mean TWSTRS part I scores without the device before and
after the trial were 16.6 and 14.7, and the scores with the device were
15.0 and 13.6, respectively. The scores without the device were sig-
nificantly decreased compared to before and after the trial
(P = 0.020), and the scores after attaching the device at the starting
the trial were significantly decreased (P = 0.001).
Conclusions: This preliminary clinical trial suggested that abnormal
head rotation of the CD was restricted by the device even without
attaching the device after the trial. This device has potential to be a
novel, less invasive, and inexpensive treatment for CD.
Improvement of table tennis dystonia by stereotactic
ventro-oral thalamotomy
Asahi T.1, Taira T.2, Ikeda K.1, Yamamoto J.1, Sato S.1
1Kanazawa Neurosurgical Hospital, Department of Neurosurgery,
Ishikawa, Japan, 2Tokyo Women’s Medical University, Department
of Neurosurgery, Tokyo, Japan
Background: Focal task-specific dystonia including writer’s cramp
and musician’s cramp is a kind of dystonia. Stereotactic ventro-oral
(Vo) thalamotomy has been performed for these movement disorders
with excellent outcome. However, there is no report on treatment for
already known sport-related dystonia by stereotactic surgery in the
literature. We treated a patient with table tennis dystonia by Vo
thalamotomy and evaluated the outcome.
Case report: A 20-year-old female left-handed table tennis player
has experienced difficulty of hitting a ping-pong ball. She has been
practicing over 4 h every day for 12 years, and could participate in
national tournaments. She experienced abnormal flexion of the left
wrist when hitting a ball at 19 years of age. The abnormal movement
appeared on the forehand stroke and, then, on the backhand, and
finally she could not continue playing. She was diagnosed as focal
task-specific dystonia by neurologists and was not recovered with
medication. She visited our hospital and underwent right Vo thala-
motomy. The surgery was performed under local anesthesia with the
patient swinging a racket during stimulation and coagulation of the
thalamus. Her symptoms improved intraoperatively just after Vo
thalamotomy. She was completely recovered from movement disor-
der, and allowed to participate in tournament again.
Conclusion: To our knowledge, this is the first report of a case
demonstrating the effectiveness of Vo thalamotomy not only for
writer’s cramp and musician’s cramp, but also for sport-related
dystonia.
Treatment of muscle dystonia with CT-guided
injections of botulinum toxin type A: technique,
indications and perspectives
Balbert A.1,2, Myakotnykh V.1,2
1Ural State Medical University, Gerontology, Ekaterinburg, Russian
Federation, 2Sverdlovsk Regional Hospital for Veterans of War,
Neurology, Ekaterinburg, Russian Federation
Clinical experience: The use of botulinum toxin type A for the
treatment of patients with different types of muscle dystonia has
shown the treatment to be not always effective. The most difficult
injections are into deep muscles. Ultrasound cannot differentiate
muscles lying deeper than 5 cm while blind needle insertion can
damage blood vessels, nerves and internal organs. Experience has
shown the best method to control the accuracy of botulinum toxin
injection is with Computed Tomography (CT). Our extensive expe-
rience in making CT-guided injections into: m. oblique inferior; m.
psoas major and m. piriformis has proven successful in minimizing
patient pain while optimizing doctors’ time and increasing patient
satisfaction.
The advantages of this method are its high accuracy and absolute
certainty in making injects into target muscles. This significantly
increases the effectiveness of treatment for patients with deep muscle
hyperactivity. The accuracy of making injections is a skill I teach.
We suggested diagnostic and treatment technique for CT guided
BTA injections in certain types of dystonia. Successful implementa-
tion improved treatment outcomes by about 30% and reduced
amounts of botulinum toxin needed by about 25% based upon com-
parisons made in our own hospital over 2 years. The results were
achieved due to proper selection of the target muscle and precise
needle placement, which I teach.
Currently, our technique has been applied in the Veterans Hospital
(Ekaterinburg, Russia). Study is ongoing to expand the applications of
CT guided BTA injections for new indications.
In the past year over 20 workshops on various techniques of
injections have been given in hospitals all over Central Russia.
Exploring the role of healthcare in the construction
of lay experts’ experience of physical disability:
a qualitative interview study of dystonia patients
in England
Bernstein C.J.1, Boardman F.1, Griffiths F.1, Sandhu H.2
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1University of Warwick, Division of Health Sciences, Warwick
Medical School, Coventry, United Kingdom, 2University of Warwick,
Clinical Trials Unit, Warwick Medical School, Coventry, United
Kingdom
Health scientists have frequently emphasised the importance of
exploring patients’ experiences of healthcare for improving services
and quality of life (QoL). Such experiences, including individuals’
perceptions of healthcare provision, have been explored in people
with dystonia using mainly quantitative measures. Yet, standardised
QoL measures have been criticised for neglecting to capture the
nuanced ways in which patients living with dystonia draw on their
illness experiences to make sense of complex healthcare decisions.
Consequently, the aim of this study is to explore how patients utilise
their embodied (physical and socio-emotional) experiences to pro-
mote, resist, and challenge healthcare practices.
This study reports on group and individual interview data with 42
adults with multiple types of dystonia. Twenty-seven people attended
local dystonia support groups and two were patients. In addition,
secondary analysis was conducted on twenty-one interviews with
thirteen patients, originally recruited for a feasibility study exploring
the self-management of dystonia. The data were thematically anal-
ysed for recurring patterns and relationships as well as deviant cases.
The interviews revealed the significance of participants’ embodied
knowledge for negotiating emotional healthcare experiences and
decisions. Many participants reported difficulties in discussing their
experiences with health professionals, utilising their embodied
knowledge to seek out other forms of health-related information,
namely from support groups and the internet. Nonetheless, partici-
pants drew productively on medical information when it aligned with
their own experiences and understandings of dystonia.
Using the findings of this study, I will argue that dystonia is
experienced holistically by those who live with it and subsequently, I
will move beyond a clinical reading of their diagnostic type to
incorporate the lived reality of dystonia. The implications of these
findings suggest that health professionals should recognise the
importance of embodied experiences to patients’ healthcare decisions
and experiences as well as the role of technology in shaping their
accounts.
20 years retraining for pianists with focal dystonia:
retrospective and perspectival methodological analysis
Boullet L.1
1Hannover Institute of Music Physiology & Musician’s Medicine
(external member), Hannover, Germany
Introduction: over the past 20 years, the retraining of pianists with
focal dystonia has become a reliable method to significantly improve
their condition. Due to a close collaboration with the Hannover
Institute of Music Physiology & Music Medicine, the integration of
fundamental research and the combination of additional medications
such as anticholinergic substances or Botox, one has achieved for the
majority of patients substantial relieves up to a professional playing
level. However, we still face crucial issues such as the general
duration of the retraining (generally 2 years or more), or the obliga-
tion to partly change highly automatized motor programs. In order to
still improve retraining approaches as well as to potentially give new
impulses to medical research, it is important to statistically evaluate
the method and find out what are the common retraining schemes
used among patients.
Method: using data protocols of more than 100 pianists retrained, it is
possible to establish basic statistics that enable us to draw a more
precise picture of the retraining. Starting with the prevalence of
compensation patterns and combining it with corresponding exercises
strategies that proved being successful, it becomes possible to
establish new schemes of focal hand dystonia phenomenon among
musicians. In addition to this method, experience has shown that a
vast variety of sensory-motor tricks still remain a valuable strategy to
regain control and reprogram the hand. Their systematic listing
matched with the correlative compensation patterns completes this
new draft after which the retraining method is now designed. It
suggests that lack of sensory-motor feedback plays a major role in the
emergence of compensation patterns together with so called predic-
tive mechanisms of movements.
Conclusion: it has become a central issue for patients to better
understand the mechanisms of focal hand dystonia. The newly
established scheme gives them a clearer picture of how FD may affect
their complex movement patterns. It is an obvious help in their
retraining strategies, not only in the deprogramming phase (reducing
compensations and lowering general muscle tone), but also in the
following reprogramming phase (acquiring new motor patterns for
basic technical approach such as scale playing) and up to repertoire
playing.
Deep brain stimulation for dystonia in the context
of medtronic-supported, investigator-sponsored
research
Brionne T.C.1, Appenrodt P.1, Mullett K.1, Sarem-Aslani A.1
1Medtronic, Clinical Research & Innovation, Tolochenaz,
Switzerland
Introduction: To foster the generation of clinical evidence, the
Medtronic Neuromodulation Clinical Research (CR) organization has
been supporting European investigator-sponsored research programs
(External Research Programs; ERPs) since the late 1990s. The sci-
entific output of these ERPs included doctoral theses and congress
presentations, but peer-reviewed publications remain the gold stan-
dard of evidence-based medicine. The purpose of this work is to
quantify this publication output based on Medtronic support, and to
characterize the Deep Brain Stimulation (DBS) for Dystonia literature
compared to the overall Neuromodulation therapies and to other DBS
research areas.
Methods: Publications were spontaneously submitted by investiga-
tors to the CR team, and to ensure thoroughness, PubMed and Embase
searches were performed using principal investigator names. Full
publications were downloaded and individually checked for relevance
to each ERP. Publication dates ranged from 1999 to 2016. Journal
impact factors retained were the latest available values, either through
direct disclosure by the journal or online databases.
Results and discussion: Medtronic-supported Neuromodulation
ERPs generated over 300 peer-reviewed publications. DBS for
Movement Disorders accounted for over 25% of this total. DBS for
Dystonia accounted for around 10% of this subgroup, and included
several publications from clinical trials with randomized controlled
assessments published in high impact journals (New England Journal
of Medicine, Lancet Neurology). Overall, studies focused on short and
long term clinical outcomes of DBS for generalized, segmental and
cervical dystonia. Few studies included disease-specific quality of life
scales or mode of action research. These publications are a key
indicator of the scientific productivity of Medtronic’s partnership with
European investigators in the area of DBS.
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Multimodal surgical treatment of generalized dystonia
Brodacki B.1, Kmiec T.2, Koziara H.3,4, Bonicki W.1,3, Mandat T.3,4
1Military Medical Institute, Neurology, Warszawa, Poland, 2Institute
Centrum Zdrowia Dziecka, Neurology, Warszawa, Poland, 3Maria
Sklodowska-Curie Oncology Memorial Center, Neurosurgery,
Warszawa, Poland, 4Institute of Psychiatry and Neurology,
Neurosurgery, Warszawa, Poland
Objective: Evaluation of effectiveness and safety of multimodal
stereotactic procedures (lesioning and deep brain stimulation (DBS))
and multifocal (globus pallidus pars interna (GPi) and subthalamic
nucleus (STN)) treatment of generalized dystonia (GD).
Background: Thalamotomy and pallidotomy are the primary
stereotactic methods of GD treatment. DBS is a surgical method of
choice for various movement disorders treatment that include GD.
Multimodal and multifocal DBS was involved in the movement dis-
orders treatment to achieve better results, but no analysis has been
conducted yet.
Methods: Seven GD patients with history of bilateral GPi DBS or
thalamotomy or pallidotomy were qualified for further surgical
treatment. All of them demonstrated significant improvement that
vanished few years after surgery. Five of them, who underwent
lesioning in the past were qualified for DBS: GPi (3 patients) and
STN (2 patient). Two patients, who underwent GPi stimulation in
past were qualified for multifocal stimulation- additional STN
DBS.
Results: Multimodal and multifocal DBS have caused sustained
improvement in dystonic movement (measured with GDS) that lasted
in two to 5 years follow-up. No surgical or stimulation related com-
plications were reported.
Conclusions: Multimodal: lesioning and DBS and combined, multi-
focal GPi and STN DBS might and should be considered when
dystonic symptoms aggravate over time.
Long lasting cerebral functional connectivity (FC)
changes of a rehabilitation perceptive integrated
approach (PIA) associated with botulinum toxin
A in cervical dystonia
Castagna A.1, Sciume` L.1, Costantini I.1, Ramella M.1, Montesano
A.1, Baglio F.1
1Don Gnocchi Foundation IRCCS Santa Maria Nascente, Milano,
Italy
Introduction: Cervical dystonia (CD) is characterized by involun-
tary, abnormal movements and postures of the head and neck. It is
currently underlined that dystonia is a network disease between
cerebellum, basal ganglia and cortex. Efficacy of Botulinum toxin
(BoNTA) has been demonstrated and there are several data that
physical therapy can improve treatment outcome acting on sensory
motor re-learning.
Methods: Five CD patients were included in the study and underwent
BoNTA injection and a rehabilitation PIA (eighteen 45 min sessions
three times a week). They were evaluated before (T0) and after
treatments (T1 at 6 week and T2 at 3 months) with Toronto Western
Spasmodic Torticollis Rating Scale (TWSTRS) and resting state
functional MRI. Imaging data of CD patients were compared with 19
age-matched healthy subjects.
Data were statistically analyzed with the repetitive measures ANOVA
corrected with Bonferroni.
Results and discussion: Data showed statistically significant
improvement in TWSTRS at T1 and persistence of the result at T2
(P\ 0.05). AT T1 patients showed FC values similar to normal
subject FC pattern. At follow up FC between sensory motor network
(SMN) and visual (VIS), pre-cuneal (PCU) and default mode (DM)
networks were still modified.
Interestingly changes between FC and clinical changes in TWSTRS
(towards lower scores) had a statistically significant correlation.
In conclusion: BoNTA associated to PIA program is efficacious in
restoring SM FC in CD patients at T1. Moreover the clinical pro-
longed effect can be due to the PIA that could facilitate the FC
between sensory motor and frontal parietal executive areas. This
could correlate with the restored motor control at T2 as demonstrated
by TWSTRS scores. Nevertheless at T2 there is a return towards
altered connectivity between sensory motor and visual cortex as
shown in T0.
A new perceptive integrated approach (P.I.A.) based
on motor learning principles associated to Botulinum
Toxin Treatment (BoNT-A) in Cervical Dystonia (CD)
Castagna A.1, Crippa A.1, Giacobbi G.1, Corrini C.1, Sciume` L.1,
Ramella M.1, Montesano A.1
1Don Gnocchi Foundation IRCCS Santa Maria Nascente, Milano,
Italy
Introduction: CD is a movement disorder characterized by invol-
untary and abnormal movements and head and neck postures that
affect daily and social life activities. The CD pathophysiologic bases
are faulty sensory-motor integration and impaired motor planning.
BoNT efficacy has been demonstrated and there are some indications
that standard physical therapy can improve symptoms. Approaches
applying sensory-motor re-learning has been suggested as an inte-
gration to standard treatment.
The PIA motor exercises have fixed temporal and spatial criteria
(open/closed eyes, laying/sitting/standing) (SaM Method) that can be
combined to obtain a tailored rehabilitation program.
The PIA also uses sensory (visual, acoustic and vibratory)
biofeedback during the exercises The devices (inclinometer,
goniometer, laser) help the patient to improve kinematic and propri-
oceptive consciousness and to re-learn correct head neck and trunk
posture and movements.
Methods: Ten patients affected by CD were included in the study. All
patients were evaluated before (T0) at 6 weeks (T1) and 3 months
(T2) after the BoNT-A treatment. CD patients underwent eighteen
45 min PIA sessions three times a week for 6 weeks. The outcome
measures was Toronto Western Spasmodic Torticollis Rating Scale
(TWSTRS). Data were then analyzed with the Wilcoxon rank test.
Results and discussion: Data showed significant improvement in
TWSTRS at T1 (P\ 0.05) and maintain the result at T2 (P\ 0.05).
The PIA has so far showed promising prolonged effects in the posture
and motor skills in patients with CD by restoring motor control and
daily life strategies. Further investigation is necessary, but the PIA
appeared to be a useful complementary treatment for patients affected
by CD.
Treatment satisfaction with botulinum toxin
among patients with cervical dystonia in Spain
Martı´ M.J.1, Catala´n M.J.2
1508 Abstracts
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1Department of Neurology, Hospital Clı´nico Provincial, Barcelona,
Spain, 2Department of Neurology, Hospital Clı´nico San Carlos,
Madrid, Spain
Introduction: The recommended treatment interval between botuli-
num neurotoxin (BoNT) injections for focal dystonia is generally
C12 weeks. However, symptom recurrence before re-injection is
common. This 2014 survey evaluated satisfaction with BoNT treat-
ment regimens among patients with cervical dystonia (CD) in Spain.
Methods: The survey included patients with CD who had received at
least three BoNT treatments. Patients were screened for eligibility in
telephone interviews and subsequently participated in an online sur-
vey 7–10 weeks after their last BoNT treatment. Participants rated
their satisfaction with BoNT treatment on a 1–10 scale (1 = not at all
satisfied; 10 = fully satisfied); ratings were obtained for satisfaction
at the time of interview, and as recalled at the peak of treatment effect
and directly before re-injection.
Results and discussion: Of the 93 participants, 44% were female.
The mean age was 51.2 years and the mean duration of CD was
10.1 years. Patients had received BoNT treatment for a mean
8.7 years with a mean treatment interval of 13.2 weeks. However, a
majority of patients (64%) reported a preference for treatment inter-
vals\12 weeks, and 32% for treatment intervals\10 weeks. At the
time of interview, 47% of patients were very satisfied (rating of 8–10)
with BoNT treatment, compared with 78% at the peak of treatment
effect and 17% directly before re-injection. The most frequent reasons
patients recalled being given by their physician for the interval chosen
were ‘to avoid antibody formation’ (70%) and ‘because shorter
intervals are not recommended’ (55%).
In conclusion, the decline in satisfaction from high levels at peak
efficacy to low levels before re-injections, and the high proportion of
patients who would prefer\12-week treatment intervals (64%) sug-
gest that patient satisfaction with BoNT treatment for CD may be
improved with more flexible, individualised injection intervals.
Status dystonicus: Refining the condition and its
management based on forty cases
Cif L.1, Nerrant E.1, Roujeau T.1, Milesi C.2, Cambonie G.2, Ros M.1,
Chan Seng E.1, Cyprien F.1, Sanrey E.1, Gonzalez Martinez V.1,
Coubes P.1
1Universite´ de Montpellier; CHRU Montpellier, Neurochirurgie,
Montpellier, France, 2Universite´ de Montpellier; CHRU Montpellier,
Pe´diatrie Ne´onatale et Re´animation, Montpellier, France
Introduction: Despite better knowledge of various forms of dystonia
and their pathogenesis, only sparse information is available for the
understanding and prognosis of increasingly worsening dystonic
conditions labelled status dystonicus (SD).
Methods: We studied a group of dystonia patients who exhibited,
during disease course, at least one episode fulfilling the previously
proposed criteria for SD. Our aim is to pinpoint indicators of pro-
gression towards SD and to further report on the long term evolution
and therapeutics, with highlight on the intensive care unit manage-
ment and deep brain stimulation effects.
Three dimensions were explored and the following parameters doc-
umented for each of them:
- Clinical characteristics (birth parameters, family history, etiol-
ogy, age at disease onset, time frame of disease progression and of
worsening towards SD, symptom type, distribution and severity, eti-
ology, medication and triggering factors of SD);
- Morphological changes documented by MRI;
- Modality of decompensation at the time of SD (hyperthermia,
rhabdomyolisis, dysphagia, weight loss, percutaneous gastrostomy,
respiratory failures, renal failure, hepatic failure, pain, sleep
alteration).
Results and discussion: Forty dystonia patients (21 female) followed
for SD in our Center were included. Age at SD ranged from 5 to
45.5 years. Dystonia was generalized in all but one patient previous to
the SD and etiology heterogeneous, remaining unknown despite
extensive investigation in 14 subjects. Dystonia was related to
mutations in TOR1A gene in 4, to PANK2 gene in other 4 and to
HPRT1 gene in 3 subjects respectively. The most frequently identified
triggering factors were therapy discontinuation or new drug admin-
istration and, inadvertent DBS discontinuation and DBS system
dysfunction during follow up for DBS. Twenty-six patients presented
DS previous to DBS administration and 22 subjects under DBS. Eight
patients died during the follow-up. The most efficient therapeutic
management was DBS with the longest follow after SD of 19.5 years.
Economics of botulinum toxin therapy: Influence
of the abobotulinumtoxinA package size on the costs
of botulinum toxin therapy
Dressler D.1, Adib Saberi F.1
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany
AbobotulinumtoxinA (Dysport) was distributed for many years in
vials containing 500MU (D500). Recently a new 300MU vial (D300)
was additionally introduced (introduction). We wanted to explore
whether more differentiated package sizes allow for more economic
use of Dysport in a large neurological botulinum toxin (BT) out-
patient clinic ([9000 standard vials/a).
The study followed a retrospective chart review design based on
our digital BT therapy data bank. All patients receiving Dysport
exclusively in a constant dose during the observation period (intro-
duction ± 7 months) were included. Economic calculations are based
on Dysport prices as officially advertised in Germany. Sharing of
vials between patients was not allowed.
Altogether 83 patients (51 with dystonia, 25 with spasticity, 3 with
hemifacial spasm, 4 with other diagnoses) were included in this study.
The total amount of MU used before and after introduction was
102525, the amount prescribed 138000MU and 116300MU (-
21700MU, -15.7%), the costs €146103 and €125250 (-€20853,
-14.3%). The price of D500 before and after introduction was
€529.36, for D300 €339.71. The D500 price for 1MU before and after
introduction is €1.0587, the D300 price for 1MU €1.1324 (+€0.073,
+7.0% against D500).
More flexible packaging reduces drug costs for BT therapy con-
siderably. Introduction of smaller packaging sizes is technically
possible and should be encouraged. Extra costs for registration and
logistics are moderate. Further cost reductions may be possible by
introduction of even smaller packaging sizes. They can be calculated
based on our model.
Mouse diaphragm assay confirms identical potency
labelling for onabotulinumtoxinA (Botox)
and incobotulinumtoxinA (Xeomin)
Dressler D.1,2, Bigalke H.1,2
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1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany, 2Toxogen GmbH,
Hannover, Germany
Labelling of botulinum toxin drugs is an ongoing matter of debate.
We wanted to test the potency labelling of onabotulinumtoxinA
(Botox) and incobotulinumtoxinA (Xeomin) in the mouse dia-
phragm assay (MDA).
For this, 5 vials of unexpired onabotulinumtoxinA 100MU (Bo-
tox, Pharm-Allergan, Frankfurt/M, Germany, 53396EW15C/
C3497C3/expiry date 10/2016, 53396W15C/C3510C3/expiry date
11/2016) and 3 vials of unexpired incobotulinumtoxinA 100MU
(Xeomin, Merz Pharmaceuticals, Frankfurt/M, Germany,
370163/expiry date 12/2016, 370163/expiry date 12/2016) were
reconstituted with 2.0 ml 0.9% NaCl/H20 without any other additives
using normal clinical equipment. 1.8 ml of each sample was added to
the organ chamber of a quality controlled MDA set-up and half-
paralysis times were recorded.
Xeomin samples produced half-paralysis times of 63, 61 and
71 min (mean ± SD, 66.0 ± 7.0 min). Half-paralysis times of
Botox samples were 70, 71, 80, 71 and 68 min (mean ± SD,
72.0 ± 4.6 min). There was no statistical significant difference
between both groups (p = 0.133, Welch’s t test).
This study shows identical potency labelling for Botox and
Xeomin. It confirms previous results obtained in a mouse lethality
assay and in various clinical studies.
Safety of botulinum toxin short interval therapy using
incobotulinumtoxinA
Dressler D.1, Adib Saberi F.1
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany
The therapeutic efficacy of botulinum toxin (BT) can be com-
pletely blocked by formation of BT antibodies (BTAB) thus
producing antibody-induced therapy failure (ABTF). One of the
risk factors for this is the interval between two subsequent injec-
tion series. To prevent BTAB formation it is universally
recommended not to use interinjection intervals of less than
12 weeks. However, BT’s therapeutic efficacy may be considerably
shorter than this interval thus causing considerable reduction of
quality of life. We wanted to study whether BT therapy with
interinjection intervals of less than 12 weeks (short interval ther-
apy, SIT) would be immunologically and otherwise safe. To
minimise the risk of BTAB formation we used incobotulinum-
toxinA which has a particularly low antigenicity.
Altogether 30 patients (age 59.2 ± 13.5 years. 19 females, 11
males) with different dystonias were included in this study. They
received SIT with incobotulinumtoxinA (Xeomin, Merz Pharma-
ceuticals, Frankfurt/M, Germany) at interinjection intervals of
69.0 ± 8.1 days (equal 9.9 weeks or 2.2 months, min.
48.9 ± 2.4 days) for 14.3 ± 2.9 injection series (equal
906 ± 169 days or 2.5 ± 0.5 years) in a dose of 259 ± 159 MU
(max. 670 ± 144.4 MU). None of the patients showed signs of
ABTF, unusual BT effects or increased adverse effects.
Information provided by this study confirms safety of SIT. With a
considerable percentage of patients hitherto undertreated for pro-
longed periods of time with BT therapy applying 12 weeks intervals,
SIT may substantially improve the quality of life for those patients.
Whether SIT is also safe with conventional BT drugs is something
that still needs to be tested.
Strategies to decrease injection site pain in botulinum
toxin therapy
Paracka L.1, Kollewe K.1, Wegner F.1, Dressler D.1
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany
Botulinum toxin (BT) is now used for numerous indications
including dystonias, spasticity, cerebral palsy, hyperhidrosis, cos-
metics and chronic migraine. It has to be injected into its target
tissues thus causing injection site pain (ISP). We wanted to com-
pare the efficacy of various analgesic interventions suggested for
ISP reduction.
In 13 healthy controls pain thresholds in the fingertips II and III
bilaterally were determined in the Mechanical Pain Threshold Test
(MPTT) and the Repetitive Pain Stimulation Test (RPST) at baseline
and under nitrous oxide/oxygen (NOO), ice spray (IS), local anaes-
thetic cream (LAC) and forearm ischaemia (FI).
All analgesic interventions studied produce statistically significant
and robust analgesic effects in the MPTT and the RPST. NOO had
stronger analgesic effects than the other interventions, although this
superiority was statistically significant only in the RPST and not
against IS.
Additionally considering duration, localisation and penetration
depth of the analgesic effect, hyperhidrosis treatment may benefit
from NOO, IS and LAC. In palmar hyperhidrosis FI is possible and
also reduces BT washout. Cosmetic indications may also benefit from
NOO and LAC. For BT therapy of spasticity, dystonia and tremor
only NOO may offer intramuscular analgesic effect. Its systemic and
prolonged effect is also an advantage in wide-spread injections in
several body parts.
Future studies are necessary to test the influence of penetration
depth and combinations of analgesic interventions.
Botulinum toxin therapy for hyperhidrosis: reduction
of injection site pain by nitrous oxide/oxygen mixtures
Paracka L.1, Kollewe K.1, Dressler D.1
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany
Injection site pain (ISP) reduces compliance of botulinum toxin
(BT) therapy considerably. We wanted to study whether nitrous
oxide/oxygen (NOO, Livopan, Linde Gas Therapeutics, Unter-
schleißheim, Germany) can reduce ISP in patients receiving
intracutaneous BT injections for axillary of palmar hyperhidrosis
(HH).
The study followed an open-label design comparing intraindivid-
ually ISP in both axillae and/or both palms when NOO was applied or
not during BT injections. BT efficacy was measured by the Hyper-
hidrosis Disease Severity Scale (HDSS) and by a 4-point Self-
Assessment Scale (SAS). ISP was documented by a Visual Analogue
Scale (VAS) and the Verbal Scale of Pain Intensity (VSPI), adverse
effects by a Structuralised Interview (SI).
Altogether 13 patients (age 34.1 ± 12.4 years, 9 females, 4 males)
were studied. 11 BT treatments were for biaxillary and 3 for bipalmar
HH. BT reduced biaxillary HH from HDSS 3.7 ± 0.5 to 1.0 ± 0 and
bipalmar HH from 3.6 ± 0.6 to 1.0 ± 0. All patients reported ISP
reduction by NOO. In axillary HH NOO reduced ISP from
55.7 ± 12.7 to 12.8 ± 7.5 on the VAS (p\ 0.05) and from 4.1 ± 0.3
to 0.7 ± 0.5 on the VSPI (p\ 0.05), in bipalmar HH from
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60.0 ± 10.0 to 13.3 ± 5.8 on the VAS (p\ 0.05) and from 5.0 ± 0
to 1.3 ± 0.5 on the VSPI (p\ 0.05). Adverse effects were not
identified.
NOO is a potent, non-sedative, quickly reversible and safe
inhalative analgesic which reduces ISP considerably in patients
receiving BT therapy for axillary and palmar HH thus substantially
improving compliance of BT therapy.
Botulinum toxin therapy: reduction of injection site
pain by pH-normalisation
Dressler D.1,2, Adib Saberi F.1,2, Bigalke H.1,2
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany, 2Toxogen GmbH,
Hannover, Germany
Botulinum toxin (BT) is injected intramuscularily and may produce
injection site pain (ISP). We wanted to explore whether the pH value
of the reconstituted BT drug contributes to ISP and, if so, what
strategies can be applied to reduce it.
In part 1 of the study, pH values of different reconstitution solu-
tions and of major BT drugs reconstituted with different
reconstitution solutions were assessed. In part 2, the effects of
reconstitution with normal saline (NS) and Ringer acetate (RA) were
compared intraindividually and in a double blind fashion in 34
patients with blepharospasm.
pH values of reconstitution solutions were 5.52 ± 0.02 for NS,
6.98 for RA, 6.31 for Ringer lactate, 6.56 for electrolyte and 5.31 for
bacteriostatic solution. pH values for NS-reconstitution were
6.09 ± 0.20 for Botox, 5.95 ± 0.24 for Dysport and 5.81 ± 0.18
for Xeomin. pH values for NS-reconstitution were 6.09 ± 0.20 for
Botox, 5.95 ± 0.24 for Dysport and 5.81 ± 0.18 for Xeomin. pH
values for RA-reconstitution were 6.95 ± 0.03 for Botox,
7.01 ± 0.02 for Dysport and 6.87 ± 0.06 for Xeomin. By using
RA instead of NS the pH could be increased by 0.86 for Botox, by
1.06 for Dysport and by 1.06 for Xeomin. 47% of the patients
experienced less ISP when Botox-RA was given rather than Botox-
NS, 76% when Xeomin-RA was given rather than Xeomin-NS.
None of the patients reported a difference in efficacy between NS-
and RA-reconstitution.
Despite previous reports, reconstituted BT type A drugs show
acidic pH values. Normalising these pH values by use of RA
instead of NS reduces ISP considerably without sacrificing clinical
efficacy.
Reconstituting botulinum toxin drugs: shaking, stirring
of what?
Dressler D.1,2, Bigalke H.1,2
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany, 2Toxogen GmbH,
Hannover, Germany
Most botulinum toxin (BT) drugs are stored as powders which need to be
reconstituted with normal saline before clinical use. As botulinum neu-
rotoxin (BNT), the therapeutically active ingredient, is a large double-
stranded protein the process of reconstitution should be performed with
special attention to mechanical stress applied. We wanted to test the
mechanical stability of BNT during the reconstitution process.
For this, 100 MU onabotulinumtoxinA (Botox, Irvine, CA, USA)
was reconstituted with 2.0 ml of NaCl/H2O. Gentle reconstitution
(GR) was performed with a 5 ml syringe, a 0.90 9 70 mm injection
needle, 1 cycle of injection-aspiration-injection and 2 gentle shakes of
the vial. Aggressive reconstitution (AR) was performed with a 5 ml
syringe, a 0.40 9 40 mm injection needle, 10 injection-aspiration-
injection cycles and 30 s of continuous shaking of the vial.
AR increased the time to paralysis in the mouse hemidiaphragm
assay (HDA) from 72.0 ± 4.6 min to 106.0 ± 16.0 min (*p = 0.002,
two-tailed t-test after Kolmogorov-Smirnova test with Lilliefors
correction for normal distribution). Construction of a calibration
curve revealed that the increase in the time to paralysis was correlated
with a loss of potency of from 100 MU to 58 MU (-42%).
BT users should use large diameter injection needles for recon-
stitution, apply two or three injection-aspiration-injection cycles and,
maybe, shake the vials a few times to rinse the entire glass wall.
Aggressive reconstitution with small diameter needles, prolonged
injection-aspiration-injection and violent shaking should be avoided.
Frontalis suspension surgery to treat patients
with blepharospasm and eyelid opening apraxia: long-
term results
Dressler D.1, Karapantzou C.2, Rohrbach S.2, Schneider S.2, Laskawi
R.2
1Hannover Medical School, Movement Disorders Section,
Department of Neurology, Hannover, Germany, 2Department of Ear,
Nose and Throat, Georg-August University, Go¨ttingen, Germany
Blepharospasm may be accompanied by eyelid opening apraxia (EOA)
reducing the efficacy of botulinum toxin (BT) therapy. The frontalis
suspension operation (FSO) is then the only effective treatment option
available. We want to report first long-term results with FSO.
We studied 15 patients with blepharospasm and EAO unrespon-
sive to BT therapy (9 females, 6 males, age 61.9 ± 11.5 years). FSO
was performed by applying 2 polytetrafluorethylen threads (PTFE,
Gore-Tex) per eye connecting the frontalis muscle to the upper eye
lid. Tension of the 2 carre´s was set to produce a palpebral fissure
width of 2–3 mm. Therapy outcome was monitored by a Quality of
Life Questionnaire (QoL-Q) and a Self-Assessment Calendar
reviewing postoperative days 0–9 (T1), 10–89 (T2), 90–179 (T3),
180–365 (T4) and[365 days (T5).
Altogether 40 FSO were performed. Postoperatively, all patients
reported improved eyelid opening, 4 (27%) complete remission of
symptoms. At T1 this improvement was 74.6 ± 26.4% on the self-
assessment scale, after 1 year 68.2 ± 27.5%. Throughout the obser-
vation period (T1–T5) the improvement was 71.9 ± 25.6%. All 19
items on the QoL-Q (except for presence of involuntary eye lid clo-
sure) showed postoperative improvement. Adverse effects included
circumscribed upper eyelid haematomas, suture extrusion, suture
granuloma, lacrimation and infections. In all patients BT therapy had
to be continued to treat orbicularis oculi contractions.
Our first long-term results demonstrate that FSO is a benign pro-
cedure producing robust and stable therapeutic effects on EOA in
blepharospasm.
Tetanus presented as hemiparesis and facial dystonia:
1 year follow up
Dulski J.1, Schinwelski M.1,2, Sławek J.1,2
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1St Adalbert Hospital Copernicus PL, Gdansk, Poland, Neurology
Department, Gdansk, Poland, 2Medical University of Gdansk,
Gdansk, Poland, Neurological and Psychiatric Nursing Department,
Gdansk, Poland
Introduction: We report a case of tetanus presenting as the facial
dystonia and hemiparesis with complete recovery and one-year video
accompanied follow-up.
Methods: A 78-year old male, who sustained an abrasion to his right
forearm, presented with dysarthria, dysphagia, prominent involuntary
painful muscle spasms in the face, blepharospasm, risus sardonicus,
trismus (lockjaw), neck muscle rigidity and mild weakness of the
distal right upper extremity. The combined treatment of human
antitetanus immunoglobulin, tetanus vaccine, penicillin, metronida-
zole and diazepam was given with no effect. He continued to worsen
and due to the risk of the respiratory failure (finally not developed) he
was sent to the Intensive Care Unit. The combined treatment was
continued and his symptoms started to improve within 2 weeks. As
the muscle rigidity has been improving, the patient developed sig-
nificant right hemiparesis. At the follow-up examination 10 months
after the accident the patient presented only slightly impaired dex-
terity of the right hand.
Discussion and conclusions: There are many reports of unusual
presentations of tetanus, however, hemiparesis is uncommon, and
to our knowledge, only one case was reported in the literature. We
highlight the variability of clinical presentation of tetanus, the need
to consider tetanus in cases of rapidly evolving muscle spasms
following peripheral injuries and provide the guidelines on tetanus
prophylaxis.
The occurrence of lateral shift in idiopathic cervical
dystonia
Esposito M.1, Peluso S.1, Dubbioso R.1, Allocca R.1, Iorillo F.1,
Coppola A.1, Santoro L.1
1Federico II University of Naples, Department of Neurosciences,
Reproductive Science and dentistry, Naples, Italy
Introduction: lateral shift (LS) of neck is an uncommon phenotype of
idiopathic cervical dystonia (CD). It seems to be an unusual presen-
tation of CD at onset and may be a phenotype that develops during
disease course and treatment with botulinum toxin (BTX). Objective
of this study is to find clinical aspects and details of the treatment with
BTX that can influence the occurrence LS.
Methods: demographic and clinical data and modalities of the
treatment with BTX of 38 consecutive patients with idiopathic CD
were analyzed on a retrospective study. Two groups were identi-
fied on the presence of LS (LS group) and the lack of LS (nLS
group).
Results: both groups of patients presented comparable demographic
and clinical data. Actually there were no significant differences of
disease and BTX treatment duration and of CD severity. The total
amount of BTX injected was also comparable but the itereside dif-
ference of dose was significantly higher in the LS group (192 ± 17.4
U vs 87,3 ± 17.9 U abo-BTX A; p\ 0.001). None of the patients of
the LS group presented neck shift at onset of CD.
Conclusions: LS may not be an original phenotype of idiopathic CD
and it could result from an imbalance of cervical muscle strength
caused by treatments with BTX prevailing on one side. LS can be
considered an effect of chronic therapy with BTX in CD with very
asymmetrical muscle contractions.
Surgical replacement of Implantable pulse generators
in deep brain stimulation: adverse events and risk
factors in a multicenter cohort
Fytagoridis A.1,2, Jiltsova E.3, Heard T.4, Samuelsson J.2, Zsigmond
P.5, Skyrman S.1
1Karolinska Institute, Department of Clinical Neuroscience,
Neurosurgery, Stockholm, Sweden, 2Umea˚ University, Department
of Pharmacology and Clinical Neuroscience, Umea˚, Sweden,
3Uppsala University Hospital, Department of Neurosurgery, Uppsala,
Sweden, 4University of Queensland, Asia–Pacific Centre
of Neuromodulation, Brisbane, Australia, 5Linko¨ping University
Hospital, Department of Neurosurgery, Linko¨ping, Sweden
Background: Deep brain stimulation (DBS) is a growing treatment
modality and most DBS systems require replacement of the
implantable pulse generator (IPG) every few years. The literature is
rather scarce regarding the potential impact of the adverse events of
IPG replacements on the longevity of DBS treatments.
Objectives: To investigate the incidence of adverse events and
postoperative infections of IPG replacements in a multicenter
cohort.
Methods: Medical records of 808 patients from one Australian and
five Swedish DBS centers with a total of 1293 IPG replacements were
audited. A logistic regression model was used to ascertain the influ-
ence of possible predictors on the incidence of adverse events.
Results: The overall incidence of major infections was 2.3% per
procedure, 3.7% per patient and 1.7% per replaced IPG. 93.3% of
these patients needed partial or complete removal. DBS removal
became permanent in 7 cases. There were statistical significant
increased risk of infection for males (OR 3.6, p = 0.026) and for each
previous IPG replacement (OR 1.6, p\ 0.005).
Conclusions: The risk of postoperative infections of IPG replace-
ments in DBS increases with each previous procedure and there is
need to develop strategies to reduce the frequency of IPG
replacements.
Bilateral pallidal deep brain stimulation for dystonia:
clinical outcome and electrode location
Pe´rez Sa´nchez J.R.1, Mateo Sierra O.2, Mun˜oz Gonza´lez A.1, De La
Casa Fages B.1, Domı´nguez Rubio R.1, Gonza´lez Quarante L.H.2,
Garbizu J.M.2, Ferna´ndez Garcı´a P.3, Guzma´n de Villoria
Lebiedziejeswki J.3, Ferna´ndez Carballal C.2, Grandas F.1
1Hospital Universitario Gregorio Maran˜o´n, Movement Disorders
Unit, Madrid, Spain, 2Hospital Universitario Gregorio Maran˜o´n,
Neurosurgery, Madrid, Spain, 3Hospital Universitario Gregorio
Maran˜o´n, Radiology, Madrid, Spain
Introduction: Deep brain stimulation (DBS) of the globus pallidus
internus (GPi) is a safe and effective treatment for generalized and seg-
mental primary dystonia. There is comparatively less experience about the
effects of GPi-DBS on acquired dystonia and only a few series analyze the
electrode location after surgery. The objective of this study is to analyze the
clinical outcome of patients with dystonia of different etiologies after GPi-
DBS and correlate it with the final electrode location.
Methods: We studied patients with dystonia treated with bilateral
GPi-DBS at our institution and currently followed. Severity of dys-
tonia was assessed by the Burke-Fahn-Marsden Dystonia Rating
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Scale (BFMDRS) and the Toronto Western Spasmodic Torticollis
Rating Scale (TWSTRS) before and after surgery. The stimulation
parameters including total electrical energy delivered (TEED1sec)
were recorded. Two neuroradiologists blinded for outcome analyzed
the anatomical location of electrodes in magnetic resonance imaging
which was compared with the preoperative target planning.
Results and discussion: 17 dystonic patients were included: 9 primary
(4 generalized and 6 segmental cranio-cervical dystonia), 7 secondary
dystonia of different etiologies (2 cerebral palsy, 4 tardive and 1 pan-
tothenate kinase-associated neurodegeneration). Mean follow-up was
59 months. 14 patients were responders with mean improvement of
61.5% in BFMDRS and 53.5% in TWSTRS. Three patients did not
improve (1 cerebral palsy, 1 tardive and 1 idiopathic segmental).
TEED1sec was 132.3 J in responders and 184.9 J in non-responders.
Precise location of electrodes was available in 11 patients (22 electrodes).
Maximal deviation from the theoretical target in the axial plane was
2 mm in one electrode of 4 patients: 2 responders and 2 non-responders.
In conclusion, bilateral pallidal deep brain stimulation is an effective
therapy for dystonia of different etiologies. Deviations from the
planned target (2 mm) in one electrode may originate a worse out-
come despite the increase in TEED1sec.
New presentation of Dopa Responsive Dystonia (DRD):
Limb atrophy and muscle weakness
Habibi S.A.H.1, Omrani F.1, Albanese A.2, Elia A.E.3
1Iran University of Medical Science, Department of Neurology, Rasool
Akram Hospital, Tehran, Iran, Islamic Republic of, 2Catholic
University, Carlo Besta National Neurological Institute, Department
of Neurology, Milan, Italy, 3Istituto Neurologico Carlo Besta, Milan,
Italy
Dopa Responsive Dystonia (DRD) is characterized by childhood
dystonia with diurnal fluctuations and dramatic and sustained
response to levodopa. Occasionally DRD is presented with other
features such as tremor or Parkinsonism.
This case report introduces Limb atrophy and muscle weakness as
a new presentation of DRD.
This case appeared to have combined neuropathy and weakness as
the presenting feature and weakness and atrophy dominated the
clinical picture.
Adult onset dystonic tics: evidence for cerebellar
involvement?
Hidding U.1, Gelderbom M.1, Ganos C.1
1Universita¨tsklinik Hamburg Eppendorf, Hamburg, Germany
Introduction: Adult-onset dystonic tics are a rare entity. To date only
a single case-series describing the clinical characteristics of 11
patients has been reported. Here, we describe a further patient with an
unusual clinical syndrome with cerebellar signs and adult-onset
dystonic tics.
Methods: Clinical and paraclinical details, alongside a video-docu-
mentation of the movement disorder are provided.
Results: A 56-year-old gentleman presented in our movement dis-
orders clinic for clinical assessment and therapeutic evaluation. At the
age of 44 he developed hyperkinesias involving the craniocervical
region, as well as his voice and arms. In addition, he reported
breathing irregularities. He also reported that since early childhood he
had difficulties with balance, particularly with his left hand. There
was no childhood history of tics. The majority of the movements
occurred unintentionally. However he was able to control the
hyperkinesias on demand, which led to an increasing sensation of
internal tension. Releasing the hyperkinesias provided a relief from
the unpleasant sensation. There was no change in the phenomenology
or severity of hyperkinesias over the years. There was no relevant
family history. Clinical examination (video) revealed multiple dys-
tonic tics, including breathing dystonia, and pseudoathetosis
involving the left arm, as well as left sided hemiataxia and spasticity.
Laboratory examinations, including acanthocytes were normal. Prior
testing for Huntington’s disease was negative. Nerve conduction
studies were also normal, but there were prolonged central latencies
for somatosensory evoked potentials. Sequential brain MRIs over a
period of 10 years showed a non-progressive in size pontomedullary
malformation.
Conclusion: This case provides further evidence to the clinical
phenotype of adult-onset dystonic tics. The unusual pontomedullary
malformation and the cerebellar signs highlight a probable role of the
brainstem and most likely cerebellum in dystonic tic pathophysiology.
Bilateral pallidal deep brain stimulation for severe
X-linked dystonia-Parkinsonism (Lubag‘s disease):
A plea for early intervention and potential
programming strategy
Sandhu M.1, Poologaindran A.1, Polyhronopoulos N.1, Honey C.R.1
1The University of British Columbia, Division of Neurosurgery,
Vancouver, Canada
Introduction: XDP (also known as Lubag’s disease) is a rapidly
progressive neurodegenerative movement disorder featuring symp-
toms of dystonia and Parkinsonism. To date, seven cases of XDP have
been treated with GPi DBS with a mean pre-operative score of 63/120
on the BFMDRS. Here, we report the most severe case ever of XDP
treated with GPi DBS and highlight a potential programming strategy
and plea for early intervention.
Methods: A 34-year-old male with family origins from Panay,
Philippines developed spontaneous cervical dystonia that was asso-
ciated with blepharospasm, difficulty opening/closing the jaw, and
dysarthria. After failing medical management and genetic testing
strongly implicating XDP, the patient immediately underwent GPi
DBS under general anesthesia. Pre-operatively, the patient scored
108/120 on the BFMDRS and 20/20 on the MDS.
Results: At the 6-month follow-up, the patient had a remarkable early
improvement as measured by the BFMDRS and MDS: 108–11/120
and 20–3/20 respectively. The patient went from being wheel chair-
bound and using a gastrostomy tube to playing sports and eating
normally, but with some residual blepharospasm and dysarthria.
Video 1 on iPad highlights pre- and post-operative (6 mo.) status of
the patient. Final stimulation parameters at 6 months were Left—
C + 0—, 3.0 V, 90 ls, 130 Hz and Right—C + 8—, 4.2 V, 90 ls,
130 Hz.
Discussion: GPi DBS was well-tolerated in this very severe case of
XDP. Despite XDP’s classification as a dystonia, our group and others
found that monopolar, not bipolar, stimulation settings resulted in the
most improvement. This programming strategy is worth testing first
before bipolar stimulation. Unfortunately, the disease appeared to
rapidly progress at the 1-year follow-up (20/120 on BFMDRS). We
highly recommend neurosurgical intervention to be considered
immediately after the time of diagnosis in order to widen the thera-
peutic window DBS offers.
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A prospective, randomized, blinded assessment
of multi-target deep brain stimulation for hemi-
dystonia: Targeting both cerebellar and pallidal
circuitry
Ivanishvili Z.1, Poologaindran A.1, Sandhu M.2, Polyhronopoulos N.1,
Honey C.R.1
1The University of British Columbia, Division of Neurosurgery,
Vancouver, Canada, 2The University of British Columbia, Vancouver,
Canada
Introduction: Dystonia is increasingly being interpreted as a multi-
nodal ‘‘network’’ disorder involving both cerebellar and pallidal cir-
cuitry. In hemi-dystonia patients who are poor or non-responders to
GPi DBS, we aimed to investigate multi-target GPi and Vim DBS
versus each target alone in a prospective, randomized, double-blinded
manner. We wish to present preliminary results of n = 2 of 6 patients
who have completed this study.
Methods: DBS leads were implanted in the contralateral GPi and
Vim for hemi-dystonia. Patients were randomized to either GPi,
Vim, or multi-target (GPi + Vim) stimulation for 3 months at a
time. At the end of each 3-month trial period, patients were eval-
uated in a double-blinded manner using the BFMDRS. After
9 months of blinded stimulation, the best setting was evaluated un-
blinded for 6 months.
Results: Multi-target (GPi + Vim) stimulation was clinically the most
effective treatment and resulted in the most improvement in function
and quality of life. The patients’ hemi-dystonia improved by 50% on
the BFMDRS in the multi-target stimulation trial period and at the
6-month follow-up. The patient’s quality of life significantly improved
and multi-target stimulation was the patients’ preferred setting.
Discussion: In addition to traditionally-viewed pallidal dysfunction
in dystonia, recent evidence indicates cerebellar dysfunction as
well. While only two patients, treating both cerebellar and pallidal
circuits appears more effective than treating a single circuit in
hemi-dystonia. Given the small sample size, caution should be
applied in generalizing these preliminary results. It is important to
appreciate that hemi-dystonia patients are typically less function-
ally impaired (on BFMDRS) compared to patients with primary
dystonia. Thus, their degree of improvement after surgery may
appear more modest and not as dramatic. Multi-target DBS should
be further explored in dystonia patients with limited or no response
to GPi DBS.
Bilateral pallidotomy for cervical dystonia after failed
selective peripheral denervation
Horisawa S.1, Kawamata T.1, Taira T.1
1Tokyo Women’s Medical University’s Medical University, Shinjyuku,
Japan
Background: We investigated the utility of pallidotomy for cervical
dystonia following failed selective peripheral denervation.
Case description: A 36-year-old man presented with cervical dystonia
with limited range of motion of the left shoulder, particularly in abduc-
tion. His Tsui score was 8. Due to the ineffectiveness of botulinum toxin
injection, he underwent selective peripheral denervation with an unsat-
isfactory outcome, with a postoperative Tsui score of 6. Simultaneous
bilateral pallidotomy was performed with local anesthesia at 1 year after
the initial surgery. The day after the pallidotomy, all dystonic symptoms
were markedly improved, except for the limited range of shoulder
abduction. The Tsui score was recorded as 1 at 1 week after the palli-
dotomy. Transient aggressive behavior was the only postoperative
complication in the present case. During clinical follow-up period of
1 year, no recurrence of the symptoms was observed.
Conclusions: Pallidotomy represents a feasible and efficacious
treatment for cervical dystonia refractory to SPD without hardware
related complications.
Stereotactic thalamotomy for the yips (sports-related
dystonia)
Horisawa S.1, Kawamata T.1, Taira T.1
1Tokyo Women’s Medical University’s Medical University, Shinjyuku,
Japan
Movement-specific involuntary movements that occur in athletes are
often called the yips. Although the underlying cause of the yips is still
controversial, it is broadly divided into the psychogenic origin
(choking) or neurological origin (task-specific dystonia). We herein
report two athletes with task-specific dystonia who diagnosed with
yips treated by stereotactic thalamotomy that resulted in substantial
success. Among patients diagnosed with yips, some can benefit from
stereotactic thalamotomy based on a concept of task-specific dystonia.
Bilateral stereotactic thalamotomy for bilateral
musician’s hand dystonia
Horisawa S.1, Kawamata T.1, Taira T.1
1Tokyo Women’s Medical University’s Medical University, Shinjyuku,
Japan
Focal hand dystonia in musician, also called as musician’s dystonia, is
a task-specific movement disorder characterized by unwanted invol-
untary muscle contraction occurring only when playing a musical
instrument. We have already reported marked improvement of med-
ically intractable unilateral musician’s hand dystonia by stereotactic
unilateral thalamotomy. Its procedure can provide immediate and
long-standing effect. We herein treated two patients with bilateral
musician’s hand dystonia by staged bilateral stereotactic thalamotomy
and they experienced marked improvement of bilateral symptoms
immediately after the surgery. Both patients became to play their
musical instruments at the same level of musical skill as before the
onset of dystonia. Transient dysarthria and hypophonia developed but
these symptoms didn’t impair their activities of daily living. No
recurrence of symptoms has been observed for over a year after each
second surgery. These outcomes indicated stereotactic thalamotomy
also can be useful for medically intractable musician’s dystonia in
both hands. This is the first report about bilateral musician’s hand
dystonia treated by bilateral stereotactic thalamotomy.
Unilateral pallidotomy for cervical dystonia
Horisawa S.1, Kawamata T.1, Taira T.1
1Tokyo Women’s Medical University’s Medical University, Shinjyuku,
Japan
Objective: We investigated the validity of unilateral pallidotomy for
cervical dystonia using severity scale of Toronto Western Spasmodic
Torticollis Rating Scale (TWSTRS, range 0–35).
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Background: Although stereotactic neurosurgery for cervical
dystonia means basically the same procedure as bilateral deep
brain stimulation (DBS) of globus pallidus internus (GPi),
lesioning of GPi (pallidotomy) for cervical dystonia is rarely
reported. Furthermore, some reports showed efficacy of unilateral
pallidal stimulation for cervical dystonia. However, efficacy of
unilateral pallidotomy for cervical dystonia has not been
investigated.
Methods: 6 patients (4 men/2 women) with cervical dystonia
underwent unilateral pallidotomy. We used severity scale of
TWSTRS as evaluation procedures before and 1 week after the
surgery.
Results: The mean age at onset and surgery were 34.7 (SD 15.3) and
47.2 (SD 11.4). The mean preoperative severity scale of TWSTRS
were 19.2(SD 4.8) and 4.7 (SD 3.9) (75.5% reduction). No periop-
erative adverse event was observed.
Conclusions: Albeit short observational period, this study suggest
unilateral pallidotomy is safe and effective procedure for cervical
dystonia.
Objective evaluation of performance stress in musicians
with focal hand dystonia: A case series
Ioannou C.I.1, Furuya S.2, Altenmu¨ller E.1
1Hanover University of Music, Drama and Media, Institute of Music
Physiology and Musicians Medicine, Hannover, Germany, 2Sophia
University, Department of Information and Communication Science,
Tokyo, Japan
Five musicians suffering from focal dystonia participated in a pilot study
which examined the feasibility of an experimental protocol designed to
assess musicians’ motor performance under stress. Electrocardiography
(ECG), free cortisol levels and subjective assessments were used to
monitor alterations of the hypothalamic–pituitary–adrenal (HPA) axis.
As measures of motor outcome, temporal variability of finger move-
ments and muscular co-contraction (EMG) of the wrist flexor and
extensor were assessed. Findings suggest that the specific experimental
design could be successfully applied. Several methodological issues such
as carryover effects, the use of free cortisol, the inclusion of a double
baseline and the classification of dystonic patients into stress responders
and non-responders are analyzed and discussed.
The impact of stress on motor performance in skilled
musicians suffering from focal dystonia: Physiological
and psychological characteristics
Ioannou C.I.1, Furuya S.2, Altenmu¨ller E.1
1Hanover University of Music, Drama and Media, Institute of Music
Physiology and Musicians’ Medicine, Hanover, Germany, 2Sophia
University, Department of Information and Communication Science,
Tokyo, Japan
Several studies have shown that motor functions can be altered under
stressful conditions. However, the impact of stress on motor performance
of musicians suffering from focal dystonia (FDM) remains largely
unknown. The current study assessed motor performance in 20 FDM
patients and 16 healthy musicians (HM) before and under stress. Stress
was manipulated using the Trier Social Stress Test (TSST). Motor
performance was evaluated during rapid scale playing based on analysis
of the electromyographic (EMG) activity (mean activity and co-con-
traction of the wrist flexor/extensor) and temporal variability (fine-motor
control), while electrocardiography (ECG) and the level of free cortisol
were used to test for objective alterations of the hypothalamic–pituitary–
adrenal (HPA) axis. Finally, the psychological profiles (based on anxiety,
perfectionistic and stress coping features) of both groups were analyzed
using psycho-diagnostic standardized questionnaires. Results showed
that patients’ motor impairments did not change under acute stressful
conditions. However, an increase in muscular co-contractions was
observed, reflecting a ‘‘normal’’ physiological muscular reaction under
stressful conditions. Psycho-diagnostic analysis revealed higher levels of
anxiety, stress and perfectionism in 40% of the patients. Although the
motor behavior between these patients and patients with an opposing
psychological profile did not differ, interestingly patients characterized
by stressful and perfectionistic personalities had, on average, developed
dystonia about10 years earlier than the rest of the patients. The current
study suggests that acute stress conditions may not have any direct
impact on fine motor control of FDM patients. However psychological
traits associated with increased stress, anxiety and perfectionism may
have a long-lasting effect on the motor function of affected musicians, by
promoting the acceleration or even the triggering of dystonia.
Dystonia, tremor, and dystonic tremor
Rosen A.1, Shaikh A.2, Jinnah H.A.1
1Emory University, Neurology, Atlanta, GA, USA, 2Case Western
Reserve University, Cleveland, OH, USA
Introduction: Dystonia is a disorder with sustained or intermittent
muscle contractions causing abnormal, often repetitive and patterned
movements or postures. In contrast, tremor is a disorder with regular
and rhythmical oscillation of a body region. While dystonia and
tremor are viewed as distinct disorders, they have close epidemio-
logical and phenomenological relationships and occur together
frequently. The goal was to provide guidance for debates regarding
the nosology of tremor in dystonia.
Methods: Subjects were recruited through 38 Dystonia Coalition sites
in North America, Europe and Australia. Subjects were at least
18 years of age and had a diagnosis of isolated dystonia. Any region
of the body could be affected, alone or in various combinations. As
part of an ongoing natural history study, all sites collected standard-
ized clinical data, including an exam that detailed presence or absence
of dystonia and tremor in each body part, type of tremor seen, and
whether tremor was the dominant clinical feature.
Results and discussion: 2301 subjects were included in the analyses.
In keeping with previous reports, a large proportion of dystonia
subjects had tremor on exam, with co-prevalence varying according to
body region affected, how dystonic tremor is defined, and variations
in enrolling sites. There are three hypothetical models to explain the
observed relationships between tremor and dystonia. (1) Tremor and
dystonia are biologically unrelated disorders, but a movement disor-
der indistinguishable from isolated tremor may sometimes occur in
dystonia. (2) Tremor and dystonia are caused by the same biological
process, with the overt clinical manifestations being pleiomorphic
consequences falling at different ends of a continuous spectrum. (3)
Tremor and dystonia are caused by different biological processes, but
they frequently overlap because the biological pathways are partially
related. Current definitions imply they are mutually exclusive disor-




Underlying heredity is associated with alcohol
responsiveness in dystonia
Junker J.1, Brandt V.1, Weissbach A.1, Lohmann K.1, Perlmutter J.S.2,
Wright L.J.2, Rosen A.R.3, Klein C.1, Jinnah H.A.3, Brueggemann
N.1, Dystonia Coalition Investigators, Dystonia Genetic Consortium
1University of Luebeck, Institute of Neurogenetics, Luebeck,
Germany, 2Washington University in St. Louis, Department
of Neurology, St. Louis, MO, USA, 3Emory University, Department
of Neurology, Atlanta, GA, USA
Introduction: Some dystonia patients show a remarkable improve-
ment of their dystonia due to alcohol use. It remains elusive whether
alcohol responsiveness is associated with the presence of (a) a posi-
tive family history, (b) dystonic tremor, or (c) a sensory trick.
Objective: To determine predictors of alcohol responsiveness in a
large cohort of dystonia patients (Dystonia Coalition Cohort).
Methods: Data from 920 patients with isolated dystonia (mean age:
60.0 ± 11.9 years, female n = 650) and no evidence of a psy-
chogenic origin of the disease were included. Patients answered a
standardized questionnaire and were clinically examined using a
standardized video protocol.
Results: Alcohol responsiveness was not related to gender (70.1%
female in the responsive vs. 70.9% in the non-responsive group,
p = 0.828) or severity of dystonia (Burke Fahn Marsden motor score
7.9 ± 9.0 vs. 7.2 ± 6.5, p = 0.587). Age at onset was lower in
patients with alcohol responsiveness (40.8 ± 15.1 vs.
47.4 ± 14.1 years, p = 0.000). Alcohol responsiveness related to a
positive family history for movement disorders (p = 0.004), presence
of tremor (p = 0.001) and an effective sensory trick (p = 0.029).
Furthermore, alcohol responsiveness differed among dystonia sub-
groups (multifocal or generalized[ focal or segmental; cervical and
laryngeal[ cranial and limb; oromandibular or lingual[ ble-
pharospasm and Meige syndrome).
Discussion: The association of alcohol responsiveness and a positive
family history for movement disorders suggests that dystonia patients
with an underlying genetic contribution may have a more beneficial
response to alcohol. Alcohol may specifically improve dystonic tre-
mor, and the presence of a sensory trick may be a clinical predictor
for alcohol responsiveness. Subgroup analyses suggest a caudo-rostral
gradient with strongest response to alcohol in patients with more
widespread dystonia and lowest improvement in blepharospasm,
which is in keeping with an association of alcohol responsiveness and
underlying heredity.
Epidemiology of spastic dystonia in stroke patients:
pilot results of SONAR study
Dornak T.1, Justanova M.2, Kanovsky P.3, Otruba P.1, Baresˇ M.2, Jech
R.4, Hoskovcova M.4, Navratilova D.1, Muzik J.5, Dusek L.5
1University Hospital Olomouc, Department of Neurology, Olomouc,
Czech Republic, 2Faculty of Medicine, Masaryk University and St.
Anne Teaching Hospital, Department of Neurology, Brno, Czech
Republic, 3Palacky University Medical School, Department
of Neurology, Olomouc, Czech Republic, 4First Faculty of Medicine,
Charles University, Department of Neurology and Clinical
Neuroscience, Prague, Czech Republic, 5Masaryk University in Brno,
Institute of Biostatistics and Analyses, Brno, Czech Republic
Objective: The main aim of the study was a point and interval esti-
mate of the incidence and prevalence of spasticity following ischemic
stroke (IS) for the regional stroke centers in the Czech Republic; the
secondary goal was to identify predictors for the development of
spasticity.
Methods: In the prospective cohort study, 221 consecutive patients
with clinical signs of central paresis due to a first-ever IS were
examined in the acute stage. All patients met following criteria:
patients with primary IS with carotid origin and neurological deficit
present longer than 7 days after the stroke onset. The degree and
pattern of paresis and muscle tone, the Barthel Index, baseline char-
acteristic and demographic data were evaluated. Spasticity was
assessed using modified Ashworth Scale (MAS) and defined as[ 1
MAS in any of the examined muscle groups.
Results: Out of 221 included patients (134 males; mean age
69.7 ± 12.0), 93 (42.1%) patients have developed spasticity during
the first 10 day after stroke onset. Seventy-six (34.4%) patients pre-
sented with mild neurological deficit (modified ranking scale 0–2) and
55 (24.9%) patients were bedridden. Spasticity was noted in 42.1%
patients with neurological deficit due to first-ever stroke in carotid
territory during the first 10 days after stroke onset. However, severe
spasticity was rare.
Funding: Supported by grant AZV MZ CR Nr. 15-31921A and by the
grant of the Internal Grant Agency of Palacky University IGA UP LF-
2016-017.
Changes in sensorimotor network activations
after botulinum toxin injections in cervical dystonia
Kanovsky P.1, Nevrly M.1, Hlustik P.1, Otruba P.1, Tudos Z.2, Hok P.1
1Palacky University Medical School, Department of Neurology,
Olomouc, Czech Republic, 2Palacky University Medical School,
Department of Radiology, Olomouc, Czech Republic
Objective: To advance the knowledge of focal dystonia patho-
physiology and further explain the changes in central
sensorimotor circuits induced by botulinum toxin injection to
dystonic muscles.
Background: The pathophysiology of cervical dystonia (CD) and
other focal dystonias has not yet been fully explained. Results from
neurophysiological and morphological studies suggest significant
involvement of the basal ganglia, thalamus and cerebellum; never-
theless, functional abnormalities in premotor and primary
sensorimotor cortical areas are considered a crucial factor in the
development of focal dystonia. Botulinum toxin A (BoNT-A) injec-
tions are the most effective, although symptomatic, treatment of CD.
Recent studies showed evidence of not only a direct effect of BoNT-A
on the neuromuscular junction, but also remotely on the central
sensorimotor circuits.
Design/Methods: Twelve patients with CD were examined with
functional MRI during a skilled hand motor task before the first
BoNT-A injection; the examination was repeated 4 weeks after the
first BoNT-A injection to the dystonic neck muscles. Twelve age- and
gender-matched healthy controls were examined using the same
protocol without BoNT-A injection.
Results: Effective BoNT-A treatment led to reduced activation of
the ipsilateral supplementary motor area and dorsal premotor
cortex. The post-treatment sensorimotor maps showed significantly
decreased basal ganglia activation. Before BoNT-A injection,
activation maps were significantly different between the patient
group and the control group, in contrast, results of the second
examination after BoNT-A injection demonstrated no significant
differences between the groups.
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Conclusion: Abnormalities in sensorimotor activation in cervical
dystonia extend beyond circuits controlling the affected body part and
its substantial change or ‘‘normalization’’ might be induced by BoNT-
A treatment.
Research supported by Institutional Support of Research Organization
MZ CR RV- FNOL 2016.
Multi target treatment of NBIA-related dystonia
with subthalamic or pallidal nucleus deep brain
stimulation
Kmiec T.1, Koziara H.2,3, Bonicki W.2,3, Brodacki B.4, Mandat T.2,3
1Institute Centrum Zdrowia Dziecka, Neurology, Warszawa, Poland,
2Maria Sklodowska-Curie Oncology Memorial Center, Neurosurgery,
Warszawa, Poland, 3Institute of Psychiatry and Neurology,
Neurosurgery, Warszawa, Poland, 4Military Medical Institute,
Neurology, Warszawa, Poland
Conservative and surgical treatment of Neurodegeneration with Brain
Iron Accumulation (NBIA) is difficult and frequently ineffective. The
authors present a group of patients with clinically and radiologically
diagnosed NBIA with genetically confirmed PANK2 mutation, trea-
ted with deep brain stimulation.
Materials and methods: Twelve patients with confirmed PANK2
mutation (NBIA-PKAN) were treated with deep brain stimulation
between 2008 and 2015. Age of the patients varied from 8 to 24 years.
The clinical condition of the patients was evaluated with scales and
video recorded. At all cases the permanent electrodes were implanted to
the subthalamic nuclei or globus pallidus. The surgical procedure was
undertaken under general anesthesia. The target was identified with
direct and indirect method. Intrasurgical macrostimulation and
microrecording were used for neurophysiological evaluation of the
target. Postsurgical local field potentials were recorded in all cases.
Results: Neither neurological deterioration nor surgical complication
were noted among the group. Caregivers of the patients noted sub-
jective improvement of the clinical state of the subjects that was
confirmed with tailored scales. More significant improvement was
noted among STN group compared to GPi group.
Conclusions: Subthalamic or pallidal deep brain stimulation reduces
dystonic movements among NBIA patients. The technique carries
minimal surgical risk, and improves quality of life of the patients.
Peripheral nerve injury leads to dystonia in DYT1
transgenic rats
Knorr S.1, Grundmann-Hauser K.2, Volkmann J.1, Ip C.W.1
1University of Wuerzburg, Department of Neurology, Wuerzburg,
Germany, 2University Tuebingen, Institute of Medical Genetics
and Applied Genomics, Rare Disease Center Tuebingen, Tuebingen,
Germany
None of the existing non-neurodegenerative rodent models of DYT1
dystonia show the typical limb-onset dystonic phenotype seen in
human. Based on the hypothesis that a ‘‘second hit’’ such as periph-
eral injury could elicit the dystonic phenotype in genetically
predisposed subjects, we induced clinically apparent dystonia in a
transgenic DYT1 rat model, that harbors the full human mutant Tor1A
gene and does not show dystonia per se, by a sciatic nerve injury.
Development of dystonia of the affected limb was investigated by
using a newly developed 0–5 point scoring: 0: no abnormal dystonic
movement; 1: short hindlimb retraction and clenching of the foot/leg
with episodes lasting\3 s or B2 repeats of hindlimb retraction and
clenching of the foot/leg; 2: hindlimb retraction and clenching of the
foot/leg with episodes lasting C3 s or C3 repeats of hindlimb
retraction and clenching of the foot/leg; 3: hindlimb retraction and
clenching of the foot/leg occurring for a total of 10 s to\50% of the
recorded time; 4: hindlimb retraction and clenching of the foot/leg
lasting a total of 50% of the recorded time; 5: hindlimb retraction and
clenching of the foot/leg for a total of[50% of the recorded time.
Dystonia duration and number of dystonic retractions of both hin-
dlimbs were added for scoring.
Two weeks after nerve injury a maximum dystonia score of *5.0
in wt and DYT1 rats was observed, followed by a slow decrease of
dystonia in both genotypes. The dystonia score decreased in wt rats
down to a minimum of *0.3 on week 10 while DYT1 transgenic rats
stayed at a higher level of about *2.0 at the same time point. Dys-
tonia after nerve injury in DYT1 transgenic rats can be revealed by
this newly established clinical dystonia scoring system.
Blepharospasm: Long-term treatment
with either Botox, Dysport or Xeomin
Kollewe K.1, Mohammadi B.2, Ko¨hler S.1, Pickenbrock H.1,
Dengler R.1, Dressler D.1
1Medical School Hannover, Neurology, Hannover, Germany,
2International Neuroscience Institute (INI), Hannover, Germany
Botulinum toxin (BT) therapy is the treatment of choice for blepharospasm
(BPS). Currently available BT type A drugs include Botox, Dysport and
Xeomin. Until now, there are few long-term studies on BT therapy for BPS.
This is the first long-term study comparing all three major BT drugs. We
collected treatment, efficacy and adverse effect data on BPS patients
treated with either Botox, Dysport or Xeomin for at least 8 consecutive
treatments. 288 patients (208 females, 80 males, age 62 ± 12 years) were
included in this study. The treatment time was 11.2 ± 4.1 years covering
10701 injection series. Doses were 47 ± 10 MU for Botox,
120 ± 35 MU for Dysport and 62 ± 11 MU for Xeomin (Botox dose vs
Xeomin dose: p\0.001, unpaired t-test). 85% of all patients had
stable doses. The onset of the therapeutic effect was after 6.1 ± 3.3 days
and its duration lasted 10.2 ± 3.5 weeks. The Global Clinical Improve-
ment (GCI, 0 = no, 1 = slight, 2 = moderate, 3 = marked improvement
in severity and function) as estimated by the patient was 2.5 ± 0.6. It was
stable in 90% of the patients. Adverse effect frequency was 3.0% (ptosis
2.3%, dry eye 0.5%, diplopia 0.2%). None of these findings was signifi-
cantly different between Botox, Dysport and Xeomin.
Our study, one of the largest studies on BT therapy of BPS and the
study with the longest follow-up, confirm that BT therapy produces
robust clinical improvement which is stable throughout the treatment
time. Adverse effects were rare, mild and always transient. BT ther-
apy is a safe and effective treatment for BSP. Shorter interinjection
intervals may improve therapeutic results.
A study of respondents to have musician’s dystonia
from a questionnaire survey performed in a music
college
Konaka K.1, Mihara M.1, Mochizuki H.1
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Background/objective: Musician’s dystonia is a task specific dys-
tonia. Though part of detail has been noticed, it is not widely
informed. Our aim was to detect the prevalence and clarify the
features.
Method: We conducted a questionnaire in two music colleges in
purpose of extracting the prevalence and characteristics of musician’s
dystonia among music students. We explained the characteristics of
musician’s dystonia on the questionnaire sheet.
Results: There were 596 valid responses from 1468 college students.
The average age of subjects was 19.8 ± 2.8 years old. There were
528 women and 68 men. There were 38 respondents answering to
have musician’s dystonia. According to previous descriptions, we
finally made a decision whether their specific symptoms are ade-
quate for musician’s dystonia. There were 10 answers (which was
0.7% of all the answers) replying to have musician’s dystonia. They
were 5 pianists, 4 brass players and 1 woodwind player. They
noticed their first symptom 9.1 ± 4.7 years after they started prac-
ticing the instruments. On the other hand, there were 28 respondents
that we decided the symptoms do not satisfy the symptoms of
musician’s dystonia. Though the majority (71.4%) of them con-
tained information of stage fright or anxiety, those were less
recognized in respondents of students judged to have musician’s
dystonia (20.0%).
Conclusions: We ascertained the prevalence of musician’s dys-
tonia in students of a music college. Disorder of musical motor
performance seems to be easily influenced by emotional stress,
therefore there is a difficulty in distinguishing musician’s
dystonia.
Meta-analytical and electrophysiological evidence
for executive dysfunction in primary dystonia
Lange F.1, Seer C.1, Salchow C.1, Dengler R.1, Dressler D.1, Kopp B.1
1Hannover Medical School, Department of Neurology, Hannover,
Germany
Impaired motor control in primary dystonia has been linked to
cortico-basal ganglia alterations that may also give rise to changes
in executive functioning. However, no conclusive evidence for
executive dysfunction in patients with primary dystonia has been
reported yet. We conducted a meta-analysis of the relationship
between primary dystonia and performance on the Wisconsin Card
Sorting Test (WCST), an established test of executive functioning.
Its results revealed a significant effect of medium size, indicating
that primary dystonia is associated with moderate performance
deficits on the WCST. Building on this finding, we conducted an
event-related potential (ERP) study to elucidate the cognitive and
neural mechanisms underlying executive dysfunction in primary
dystonia. Eighteen patients with blepharospasm, a common form
of primary focal dystonia, and 34 healthy matched controls
completed a computerized version of the WCST. We specifically
compared indicators of two distinct components of executive
functioning: set shifting and rule inference. On a behavioral level,
blepharospasm patients seemed to have particular difficulty inte-
grating information to infer the correct task rule. In addition, P3a
amplitude (as an electrophysiological marker of rule-inference
processes) was selectively attenuated in blepharospasm patients.
Executive dysfunction in blepharospasm can thus be attributed to
a selective rule-inference deficit, whereas set-shifting abilities are
largely unaffected by the disease. Moreover, P3a amplitude
attenuation was related to disease duration, indicating that this
ERP might serve as a neural indicator of disease progression and
executive dysfunction in primary dystonia. These results demon-
strate for the first time that pathophysiological alterations in
primary dystonia might affect cortical activation for executive
functioning.
German registry of pediatric deep brain stimulation
in patients with childhood-onset dystonia
(GEPESTIM): Adverse events
Koy A.1, Hellmich M.2, Ku¨hn A.A.3, Krause P.3, Huebl J.3, Schneider
G.-H.3, Weinsheimer M.1, Deuschl G.4, Erasmi R.4, Falk D.4, Visser-
Vandewalle V.1, Pauls K.A.M.1, Schnitzler A.5, Wojtecki L.5, Vesper
J.5, Korinthenberg R.6, Coenen V.A.6, Lu¨tjens G.7, Krauss J.K.7,
Timmermann L.1, GEPESTIM study group
1University Hospital Cologne, Cologne, Germany, 2University
of Cologne, Cologne, Germany, 3Charite´ University Medicine Berlin,
Berlin, Germany,
4University Hospital of Schleswig–Holstein, Campus Kiel, Kiel,
Germany, 5University Hospital of Du¨sseldorf, Du¨sseldorf, Germany,
6Freiburg University Medical Centre, Freiburg, Germany, 7Medical
School, MHH, Hannover, Germany
Introduction: Data on adverse events (AEs) in pediatric patients
undergoing deep brain stimulation (DBS) is limited, especially for
long-term outcomes, because of small numbers in single center series
and lack of multi-center trials.
Methods: A German registry on pediatric DBS (GEPESTIM) was
created to collect data of patients with dystonia and DBS up to the age
of 18 years. All postoperative AEs were documented.
Results: So far, data of 44 patients (mean age 12.8 years at time
of implantation) have been included in the registry. 61 AEs were
documented for 31 patients. IPG replacement due to battery
expiry was the most common reason for surgical intervention. In
15 patients 20 IPGs had to be removed due to depleted batteries
after an average time after last implantation of 3.7 ± 1.8 years.
Infections and wound healing problems were other frequent
indications for hardware removal or replacement. Reversible
causes included fever, wound infection, and stimulation induced
side-effects. Analysis of the (mean) number of AEs in relation to
different age groups at time of surgery and time of follow-up
revealed that patients aged 7–9 years at time of surgery had the
highest number of AEs per patient (2.0) up to 4 years after
implantation.
Discussion: The number of AEs associated with pediatric DBS
seems similar to previous reports, but higher than in adult
patients undergoing DBS. The high rate of infection might be
attributed to severe motor impairment and undernourishment,
which is commonly seen in pediatric patients suffering of
acquired forms of dystonia. Therefore, the use of antibiotics
should be reconsidered. In view of the frequent IPG replacements
due to battery expiry, the implantation of rechargeable IPGs may
be favorable.
Conclusion: Comprehensive assessment of effects and AEs is of
imminent importance to create standardized management algorithms
in order to improve DBS treatment in young patients.
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Quantification of instability of tone production
in embouchure dystonia
Lee A.1,2, Furuya S.2,3, Morise M.4, Altenmu¨ller E.2
1Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen,
Department of Neurology, Mu¨nchen, Germany, 2University of Music,
Drama and Media Hannover, Institute for Music Physiology
and Musicians’ Medicine, Hannover, Germany, 3Sophia University,
Department of Information and Communication Sciences, Tokyo,
Japan, 4University of Yamanashi, Interdisciplinary Graduate School
of Medicine and Engineering, Kofu, Japan
Objective: Musician’s dystonia is a task-specific loss of voluntary
control of the motor system such as fingers or the embouchure. In
contrast to pianists’ dystonia which can be objectively assessed based
on movement kinematics and muscular activities, no quantitative
measure has been established for embouchure dystonia.
Methods: We focused on acoustic signals, and investigated, whether
the fluctuation of the time-varying fundamental frequency of a note can
provide an objective and reliable measure of embouchure dystonia.
Results: A comparison between patients with embouchure dystonia
and healthy controls found a significantly higher variability of the
fundamental frequency for the patients.
Conclusion: The present findings propose a new quantification
method for embouchure dystonia.
Fixed dystonia of the left hand in a violinist, a rare
functional disorder
Lee A.1,2, Jahnke A.3, Altenmu¨ller E.2
1Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen,
Department of Neurology, Mu¨nchen, Germany, 2University of Music,
Drama and Media Hannover, Institute for Music Physiology
and Musicians’ Medicine, Hannover, Germany, 3St. Joseph’s
Hospital, Ennis, Ireland
Background: Fixed dystonia leads to an immobile abnormal pos-
turing of the affected limb. It is an ongoing debate whether this
condition is psychogenic in origin.
Case report: We present a 21 year old violinist with fixed dystonia
after an acute overuse injury with a transient cyanosis but no signs for
psychological trauma. After Incobotulinumtoxin-injection symptoms
subsided within 8 h.
Discussion: Our case corroborates the notion that fixed dystonias after
minor injuries are functional disorders. It underlines the necessity of a
biopsychosocial approach to functional disorders, considering the
possibility of an overlay between organic and non-organic disorders.
Coherence of coactivation and acceleration in task-
specific primary bowing tremor
Lee A.1,2, Tominaga K.3, Furuya S.2,4, Miyasaki F.3, Altenmu¨ller E.2
1Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen,
Department of Neurology, Mu¨nchen, Germany, 2University of Music,
Drama and Media Hannover, Institute for Music Physiology
and Musicians’ Medicine, Hannover, Germany, 3Osaka University,
Department of Engineering Science, Osaka, Japan, 4Sophia
University, Department of Information and Communication Sciences,
Tokyo, Japan
Background: Primary bowing-tremor is a task-specific tremor that
may occur in the right arm of violinists. We recently showed that a
coactivation of wrist antagonist muscles, however, a direct relation-
ship could not be shown between either coactivation and tremor or
between EMG-activity and tremor.
Methods: Coherence between coactivation and tremor and EMG-
activity and tremor was assessed.
Results: We found coherence between coactivation of wrist antago-
nist muscles and tremor as well as between EMG-activation and
tremor in patients at a frequency-range of 3–8 Hz. No coherence was
found in healthy controls.
Conclusion: Our findings show a direct relationship between coac-
tivation and tremor. The direct relationship of antagonist coactivation
and tremor may indicate that task-specific tremors are a manifestation
of task-specific dystonia, where coactivation is a main feature. The
coherence between EMG-activity and tremor corroborates our pre-
vious notion that PBT emerges mainly due to central neurogenic
contributions via motor-unit-synchronization.
Homozygous mutations in SACS, ATCAY,
and MCOLN1 in three Pakistani families with dystonic
features
Lohmann K.1, Manzoor H.1,2, Ba¨umer T.1, Hinrichs F.1,
Hussain H.M.J.3, Wajid M.4, Naz S.2, Bru¨ggemann N.1,5,
Mu¨nchau A.1,6
1University of Luebeck, Institute of Neurogenetics, Lu¨beck, Germany,
2University of the Punjab, School of Biological Sciences, Lahore,
Pakistan, 3University of the Punjab, Department of Microbiology
and Molecular Genetics, Lahore, Pakistan, 4University of Education,
Lahore, Pakistan, 5University of Luebeck, Department of Neurology,
Lu¨beck, Germany, 6University of Luebeck, Department of Paediatric
and Adult Movement Disorders and Neuropsychiatry, Lu¨beck,
Germany
Introduction: A number of genetic causes of autosomal dominant
dystonias have been identified, however genes for recessive forms
remain largely unknown. Recessive causes can best be elucidated in
consanguineous families using next generation sequencing.
Methods: We collected five Pakistani consanguineous families with
dystonic features in multiple affected individuals. Patients were
videotaped and clinically evaluated by neurologists. We performed
exome sequencing in 4–5 samples per family. Variants were filtered
based on homozygosity in patients, predicted protein-sequence
change, and frequency in public databases. Segregation of candidate
variants was tested in all available family members by Sanger
sequencing.
Results and discussion: In Family RDHM-01, the disease was
characterized by ataxia of gait, bradykinesia including hypomimia,
mild dystonic postures of upper limbs, supranuclear gaze palsy, and
spasticity with onset at the age of 1.5 year. In all four patients, we
identified a novel, homozygous 1-basepair duplication (c.9119dup;
p.Asn3040fs) in the SACS encoding sacsin, mutations in which caused
spastic ataxia of the Charlevoix-Saguenay type. In Family RDHR-04,
a homozygous 7-basepair deletion (c.599_605del; p.Pro200fs) was
found in all five patients in ATCAY encoding caytaxin, mutations in
which cause Cayman cerebellar ataxia. Our patients had severe gait
ataxia, mild bibrachial dystonia, strabism, apraxia, and a suspicion of
cognitive impairment with onset at the age of about 4 months.
Finally, in Family RDHM-03, a homozygous missense mutation
(c.551T[C; p.Ile184Thr) was found in MCOLN1 encoding mucolipin
1. Both patients in this family had adolescence-onset generalized
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dystonia. Of note, mutations in MCOLN1 cause mucolipidosis IV, a
neurodegenerative lysosomal storage disorder. None of these muta-
tions was found in 200 ethnically matched controls. In conclusion,
exome sequencing is a powerful tool to detect disease-causing vari-
ants particularly in genes that would not be picked for diagnostic
testing by Sanger sequencing.
PEDiDBS: On the introduction of the international
pediatric DBS registry
Marks W.1,2, Sanger T.3, Bailey L.1,4, Koy A.5, Lin J.-P.6, Mink J.7,
Timmermann L.5
1Cook Children’s Medical Center, Neurosciences, Fort Worth, TX,
USA, 2University of North Texas Health Sciences Center, Pediatrics,
Fort Worth, TX, USA, 3University of Southern California, Los
Angeles, CA, USA, 4University of North Texas Health Sciences
Center, Fort Worth, TX, USA, 5University of Cologne, Cologne,
Germany, 6Evelina Children’s Hospital, London, United Kingdom,
7University of Rochester, Rochester, NY, USA
Although deep brain stimulation has been utilized for adult patients
since 1997, DBS has only been available for the treatment of pediatric
patients with dystonia since 2003. In the United States, there is an
FDA HDE imposed lower age limit of 7 years. Although a few
centers have developed significant experience with pediatric patients,
most children worldwide are implanted in adult centers or pediatric
centers with small surgical volumes. Additionally, there is a low
incidence of disorders for which DBS may be applicable in childhood.
There are many questions about the role of DBS in children that can
only be answered by collective shared experience. An international
registry has been developed to capture experience from centers large
and small regarding pediatric patients undergoing DBS implantation.
The registry is open to any center implanting a child aged 21 years or
younger with DBS. There is no restriction with regard to the under-
lying disorder, implant site, surgical technique. Participation is
voluntary. A limited data set is utilized and data is stored securely in
accordance with privacy laws. Sites are identified only by number and
retain access to their own data. A data oversight committee is
responsible for the management of access to collective data for
research purposes. Information and request for participation is
available at http://www.pedidbs.org.
Deep brain stimulation in pediatrics: the dystonia
experience at Cook Children’s Medical Center
Marks W.1,2, Bailey L.1,2, Reed M.1, Acosta F.1, Honeycutt J.1
1Cook Children’s Medical Center, Fort Worth, TX, USA, 2University
of North Texas Health Sciences Center, Fort Worth, TX, USA
Introduction: Deep brain stimulation received United States
approval for dystonia in 2003. Since 2007 we have offered Deep
Brain Stimulator (DBS) placement in pediatric movement disorder
patients at Cook Children’s Medical Center. We have modified our
surgical approach to help increase efficacy and minimize morbidity.
Methods: A retrospective review was performed on our first 100 DBS
patients. All patients enrolled for DBS surgery at Cook Children’s
Medical Center undergo an IRB approved consent process in accor-
dance with the USFDA Humanitarian Device Exemption status of this
device for dystonia.
Results: One hundred patients underwent primary implants. Among
our dystonia patients, the first 83 patients were done awake with
microelectrode recordings (MER). Our last 17 GPi lead placements
were done under general anesthesia using the Clearpoint MRI guided
system. TMean aCP patients with a slight male predominance in both
groups. Primary dystonias accounted for 30% of MER and 56% of CP
implants. Surgical complications among MER patients included 11
infections in 8 patients, strokes or hemorrhages in 7 patients. Eleven
MER patients required lead relocation for inadequate efficacy. In the
CP group, there has been one epidural hemorrhage during frame
placement and one infection (5.0%). Postsurgical hardware compli-
cations include 8 extension wire and 4 lead fractures, all in patients
with dystonia.
Conclusion: Over the last 9 years, we have modified our surgical
approach to minimize complications (i.e., more lateral trajectory
to decrease strokes/hemorrhage, two-stage placement to decrease
infection, and asleep surgery to increase comfort). DBS remains
an important tool in the management of carefully selected patients
with medically refractory movement disorders. Although compli-
cations remain problematic in the pediatric population, they can
be reduced with experience and improvements in surgical
techniques.
Botulinum toxin treatment of freezing of gait
in Parkinson’s disease patients as reflected in functional
magnetic resonance imaging of leg movement
Vastik M.1, Hlustik P.1, Otruba P.1, Mensikova K.1, Hok P.1, Tudos
Z.2, Kanovsky P.1
1Palacky University Medical School, Department of Neurology,
Olomouc, Czech Republic, 2Palacky University Medical School,
Department of Radiology, Olomouc, Czech Republic
Background: Freezing of gait (FOG) is a common disabling symp-
tom in Parkinson’s disease (PD). The mechanism of FOG in not
clearly understood, nevertheless, the dystonia of lower limb muscles
was discussed. We investigated the clinical effect and changes of the
activity of the sensorimotor system using functional MRI (fMRI)
examinations before and after application of botulinum toxin in
Parkinson’s disease patients with FOG.
Methods: 20 patients with PD, 10 with FOG and 10 without FOG
were examined. PD patients with FOG were treated with intramus-
cular application of botulinum toxin type A into the tensor fasciae
latae muscle bilaterally. The clinical effect of treatment was assessed
using FOG questionnaire, ‘‘Time up and go’’ test, UPDRS, Hoehn and
Yahr staging and GCI scale. Activation of the sensorimotor system
was studied using BOLD fMRI of the whole brain during repetitive
abduction–adduction of each leg interleaved with rest. The clinical (in
the FOG group) and imaging (in both groups) examination was
repeated after a four-week interval.
Results: In the FOG group, the FOG questionnaire has shown a
decline of scores after application of botulinum toxin that suggests
possible effect of botulinum toxin on freezing of gait. In fMRI results,
both groups manifested reduction of the sensorimotor network acti-
vated with leg movement, however, the FOG group also showed
increased activation in cerebellar vermis and nuclei, in dorsal pons
and in medulla after treatment.
Conclusion: Alleviation of the FOG in PD patients by botulinum
toxin seems to be reflected in the functional participation of the
cerebellum and its projections as seen by fMRI.




The effects of internal globus pallidus deep brain
stimulation on dystonia - preliminary results
Merrouche B.1, Guenane L.1, Abdennebi B.1
1Faculty of Medicine, Hospital Salim Zemirli, Department
of Neurosurgery, Algiers, Algeria
Introduction: Dystonia is a syndrome characterized by involuntary
sustained muscle contractions that result in twisting, repetitive
movement and abnormal posture. Dystonia is typically classified by
age of onset, origine, and affected body region. When the cause is not
defined or unknown, the dystonia is referred to as idiopathic or pri-
mary dystonia. Primary dystonia can be familial.
Materials and methods: 27 patients (15 males and 12 females)
underwent this surgical technique. Ranging in AGE from 07 to
57 years, generalized dystonia (19 patients) and localized (08
patients), Electrodes were bilaterally implanted under stereotactic
guidance and connected to neurostimulateurs. Efficacy was evaluated
by comparing scores on the clinical and functional Burke-Marsden-
Fahn dystonia rating Scales (BMFDRS) before and after implantation
(3 and 6 months and 1 year postoperatively). The operation was
performed under standard general anesthesia.
Results: After 3 months the improvement of the clinical score was
40%, the functional score was improved by 22%. After that, at
6 months it was respectively: clinical: 56% and functional: 41%;
Finally at 1 year: the improvement concerned the clinical score: 80%
and the functional score: 85%.
Conclusion: Bilateral chronic electrical stimulation can be pro-
posed as first line treatment for generalized dystonia. It is
conservative, adaptable, reversible and well tolerated by the
pediatric population. It must be applied as soon as possible,
especially in primary dystonia.
Tolerance is excellent and the complication rate remains low.
Task-specific dystonia in Brazilian musicians
Moura R.D.C.1, Aguiar P.M.2, Bortz G.3, Ferraz H.B.1
1Federal University of Sa˜o Paulo, Neurology, Sa˜o Paulo, Brazil,
2Hospital Albert Einstein, Brain Institute, Sa˜o Paulo, Brazil, 3State
University of Sa˜o Paulo, Sa˜o Paulo, Brazil
Background: Musician’s dystonia is a task-specific focal dystonia that
can occur in any part of the body, most commonly on the face, neck
muscles and upper limbs. Its frequency among the Brazilian population
is unknown. This study aimed to assess the complaints of musicians
with performance problems attributed to motor difficulties and to assess
the frequency and clinical profile of musician’s dystonia in Brazil.
Methods: To identify individuals with dystonia, we visited orchestras
and music schools in 19 Brazilian cities between March 2013 and
March 2015, providing information about task-specific dystonia
(TSD). Musicians were invited to answer a questionnaire, and those
with possible neurological dysfunction were filmed while performing.
In total, 2232 questionnaires were completed, with 72 subjects
recorded on video in specific tasks and also were submitted the
assessment of anxiety states and the severity of dystonia.
Results: In total, 49 individuals were diagnosed with TSD (mean age
36.4 (±) 12.2 years; 92% male). The instruments most associated
with TSD was the guitar acoustic (36.75%) and the brass instruments
(30.6%).
Conclusion: Our results suggest that the frequency of focal dys-
tonia among musicians in Brazil is 2.2%, it can initially appear
around 30 years old and is mostly associated with males, profes-
sional musicians who play classical concert music and in people
who perform other activities using their upper limbs. Muscu-
loskeletal injuries appear prior to the onset of dystonia. TSD is a
condition that deserves further attention from musicians, teachers
and health professionals.
Changing treatment between Ona-botulinumtoxin-A
and Abo-botulinumtoxin-A in cervical dystonia,
hemifacial spasm and blefarospasm. A cross-over study
Nazarian N.1, Danielsen E.1
1Aarhus University Hospital, Dept. of Neurology, Aarhus, Denmark
Introduction: No guidelines are available for changing treatment
between the different botulinum neurotoxins (BoNTs).The aim of this
study was to find the effective conversion ratio between Ona-bo-
tulinumtoxin-A (Botox)/Abo-botulinumtoxin-A (Dysport) therapy.
In addition, the effect of using Ona-botulinumtoxin-A and Abo-bo-
tulinumtoxin-A on patients with dystonia, who have been followed up
in the range of 1991–2014, is reported.
Methods: The doses of Ona-botulinumtoxin-A were collected for
minimum a year when stable optimal treatment doses were achieved.
Each patient was then changed to treatment with Abo-botulinum-
toxin-A. The effects were estimated by the visual analogue scale
(VAS). The average conversion ratio of Ona-botulinumtoxin-A/Abo-
botulinumtoxin-A was estimated when stable optimal treatment doses
were found.
Results: 55 patients were included in this study. 4 patients had ble-
pharospasms and treatment time was 13.25 ± 2.21 years. We
samples 126 injection series. Doses were 27.075 ± 10.63 MU-Ona-
botulinumtoxin-A and 75.71 ± 36.04 MU-Abo-botulinumtoxin-A. 3
patients had hemifacial spasms- treatment time was 13 ± 3 years and
we sampled 125 injection series. Doses were 14.02 ± 8.06 MU-Ona-
botulinumtoxin-A and 63.75 ± 53.657 MU-Abo-botulinumtoxin-A.
48 patients had cervical dystonia- treatment time was
15.75 ± 4.58 years and we sampled 2546 injection series. Doses
were 126 ± 38.77 MU- Ona-botulinumtoxin-A and 381.6 ± 151.1-
Abo-botulinumtoxin-A.The effect range is 20–100% by both BoNTs.
The conversion ratio for blepharospasm was 1: 2.94. For hemifacial
spasm 1: 3.03, and for cervical dystonia the ratio was 1: 2.56.
Discussion: By considering the effects, the conversion ratios and the
long follow-up period, this study shows that it is safe and satisfying
for changing treatment from Ona-botulinumtoxin-A to Abo-bo-
tulinumtoxin-A at the found conversion ratios.
Subtle sensory abnormalities in patients with segmental
and cervical dystonia detected by quantitative sensory
testing
Paracka L.1, Wegner F.1, Blahak C.2, Abdallat M.3, Karst M.4,
Dressler D.1, Krauss J.K.3
1Hannover Medical School, Department of Neurology, Hannover,
Germany, 2University of Heidelberg, Faculty of Medicine Mannheim,
Department of Neurology, Heidelberg, Germany, 3Hannover Medical
School, Department of Neurosurgery, Hannover, Germany,




Sensory abnormalities are increasingly being recognized as an
accompanying symptom in patients with isolated inherited or idio-
pathic dystonia. The aim of this study was to investigate whether
sensory abnormalities would be related to age and to the distribution
of motor symptoms in patients with primary dystonia. For this pur-
pose we recruited 20 dystonic patients, from which 8 had generalized
dystonia, 7 cervical dystonia and 5 segmental dystonia with hand
involvement and compared them with age matched controls. We used
Quantitative Sensory Testing (QST) on the back of the hand in all
patients and on the shoulder in patients with cervical dystonia. The
patients with involvement of the hand in dystonia were divided into
two groups: younger than 40 years of age (6 patients) and older than
40 (7 patients). All patients with cervical dystonia were older than 40.
The QST values were compared to 19 age matched controls. Our
results show that younger patients with hand dystonia have both
impaired cold pain threshold (CPT) and hot pain threshold (HPT) on
the side more affected by dystonia, and also impaired mechanical pain
sensitivity (MPS) on both sides. Patients older than 40 have a
diminished cold detection threshold (CDT) and thermal sensory limen
(TSL) on the side more affected by the disease and diminished MPS
of the hand on both sides. Patients with cervical dystonia have an
increased hot detection threshold (HDT), CDT, TSL and MPS on the
back of the hand. In the group with cervical dystonia, the shoulder
QST revealed impaired CDT and MPS. QST clearly shows several
subtle sensory abnormalities in patients with inherited or idiopathic
dystonia. Whether or not altered sensory function in dystonic patients
correlates with the degree of dystonia needs further clarification.
Key words: Dystonia, QST, sensory abnormalities.
The first and second authors contributed equally.
The Technical Ability and Performing Scale (TAPS):
a proposal of a new functional rating scale
for Musicians Focal Dystonia (MFD)
Ramella M.1, Giacobbi G.1, Castagna A.1, Converti R.M.1
1Don Gnocchi Foundation IRCCS Santa Maria Nascente, Milano,
Italy
Objective: The aim of this study is to present a new functional rating
scale for MFD.
Background: The available rating scales for MFD suffer from lack of
sensitivity to verify the clinical changes, especially during rehabili-
tation, and are not digit-specific.
TAPS is a self-evaluation scale made up of seven visual analogical
scales. Six items investigate the motor disorder extent while the
musician is playing different technical passages (TP) while the sev-
enth evaluate the last week global performance (PS). The Technical
Ability (TA) is the six TP median value. The six TP are: the chro-
matic scale at three increasing speed (V1, V2, V3), the C-major scale
ascending/descending (CS), a piece and a TP chosen by musician. For
drummers instead of V1, V2, V3 and CS we asked to perform two
basic TP and one of them at three increasing speed. All the items had
to be played for 45 s at specific speed. The musician had to assign the
score just at the performance end. If they were unable to complete the
task we assign them a zero.
Methods: We evaluated 38 patients with the TAPS, the Arm Dys-
tonia Disability Scale (ADDS). All musical instruments and type of
MFD were included. The data were statistically analyzed with the
Spearmen rank order correlation test and Cronbach’s.
Results: Cronbach’s among the six TP was 0.79. TA was positively
correlated with all TP (p\ 0.05) and negatively with ADDS
(r = -0.36, p\ 0,05), the age (r = -0.3, p\ 0.05) and the onset
age (r = -0.40, p\ 0.05). PS is significantly correlated only with
ADDS. TA doesn’t correlate with PS.
Conclusions: The data had showed that TAPS is a tailored useful tool to
evaluate the FD subjective perception and the quality of performance.
A new integrated rehabilitation protocol to treat
musician focal dystonia (MFD)
Ramella M.1, Bologna C.1, Giacobbi G.1, Castagna A.1,
Converti R.M.1
1Don Gnocchi Foundation IRCCS Santa Maria Nascente, Milano,
Italy
Objective: The aim of this study is to assess the effectiveness of an
integrated rehabilitation protocol, based on SaM (Sense and Mind)
Method’s and Mirror Therapy’s principles on MFD.
Background: MFD is a movement disorder affecting 1 in 200–500
instrumental musicians and can lead to the end of the musical carrier.
A variety of treatments have been proposed such as oral medications,
retraining, biofeedback, constraint-induced therapy, splinting, botu-
linum toxin. The Mirror Therapy, such as Laterally Construction,
Motor Imagery and Mirror Box, has been used for the treatment of
phantom limb pain, complex regional pain syndrome and stroke
rehabilitation. SaM Method is a spatial rehabilitation approach which
has the goal to improve, through specific motor exercises, perception
and action; it has been used to treat TBI, stroke rehabilitation.
Methods: Fourteen musicians affected by FD, referred to the ‘‘Sol
Diesis Service’’ of the Don Gnocchi Foundation, were included in the
study. All musical instruments and type of FD were included. The
patients followed a 10 weeks protocol. All musicians had to evaluate
themselves before and after the treatment by using the Technical
Ability and Performing Scale (TAPS). TAPS is a functional scale
made up of visual analogical scale that investigates the motor disorder
extent while musicians are playing six different musical items and the
global performance (PS). The Technical Ability (TA) is the six
technical items’ median. The data were statistically analyzed with the
Wilcoxon rank test.
Results: The data analysis showed statistically significant changes for
TA (p\ 0.005) for TA and for PS (p\ 0.001).
Conclusions: Further investigation is necessary, but the integrated
rehabilitation protocol appears to be a useful complementary treat-
ment for musician affected by FD.
A combined behavioural and mindfulness programme
for people living with Dystonia: results of a feasibility
study
Sandhu H.1, Bernstein C.2, Davies G.3, Tang N.K.Y.2, Belhag M.4,
Tingle A.5, Field M.5, Foss J.2, Lindahl A.4, Underwood M.2,
Ellard D.2
1University of Warwick, Clinical Trials Unit, Coventry, United
Kingdom, 2University of Warwick, Coventry, United Kingdom,
3University of Southampton, Southampton, United Kingdom,
4University Hospitals Coventry and Warwickshire NHS Trust,
Coventry, United Kingdom, 5The Dystonia Society (West Midlands
Group), Solihull, United Kingdom
Introduction: Dystonia (a neurological condition) refers to a range of
movement disorders typically characterised by tremor and movements
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affecting one or more sites of the body and/or abnormal postures from
sustained muscle contractions. Quality of life (QoL) can be diminished
leading to higher risks of depression and anxiety. There is a lack of
evidence for psychological and behavioural interventions, improving
QoL in Dystonia. Mindfulness is shown to improve patient health
outcomes for those with chronic conditions. The aim of this study was
to test the feasibility of an intervention integrating psychological,
behavioural and mindfulness principles for those living with dystonia.
Methods: A total of 12 participants (from a NHS Botulinum Toxin
Clinic) consented to attend a three-day group residential programme
led by a psychologist and a mindfulness expert. A detailed process
evaluation consisting of pre and post participant interviews and pro-
gramme observation was completed. Quantitative data for health and
wellbeing, mood and anxiety were collected at baseline, 1- and
3-month using validated questionnaires.
Results and discussion: Nine participants completed the whole
programme. Analysis of interview data (using NVIVO) showed that
overall participants found the programme useful and it was very well
liked. Learning about their condition was insightful, and they felt they
had new strategies to help self-manage their dystonia. The mindful-
ness was received positively with all participating in the practical
sessions. The residential and group format was received positively.
There was a positive trend indicated in mean scores for wellbeing,
anxiety, depression and global dystonia.
In conclusion, we have successfully delivered a three-day residential
programme to help those living with dystonia combining psycho-
logical, behavioural and mindfulness principles. Feedback was useful
and will be considered in the next stage of a randomised controlled
trial to test the efficacy and cost effectiveness of the programme
against best usual care.
Deafness-dystonia syndrome
Schinwelski M.1,2, Dulski J.1, Mandat T.3, Pienczk-Re˛cławowicz K.4,
Sławek J.1,2
1St Adalbert Hospital Copernicus PL, Gdansk, Poland, Neurology
Department, Gdansk, Poland, 2Medical University of Gdansk,
Gdansk, Poland, Neurological and Psychiatric Nursing Department,
Gdansk, Poland, 3Department of Neurosurgery, Maria Skłodowska-
Curie Institute of Oncology, Warszawa, Poland; Department
of Neurosurgery, Institute of Psychiatry and Neurology, Warszawa,
Poland, Warszawa, Poland, 4Department of Developmental
Neurology, Medical University of Gdansk, Gdansk, Poland
In this report we present a patient with deafness-dystonia syndrome
of unknown cause, refractory to medical treatment, who has been
successfully treated with deep brain stimulation of the internal
globus pallidus (GPi-DBS) and followed-up for 4 years. To our
knowledge, only two cases of this syndrome treated with deep brain
stimulation have been reported till now. The Burke-Marsden-Fahn’s
Dystonia Rating Scale improved from 75 points before surgery to 10
and 15 points, at 3 months and 4 years, respectively, after the
surgery.
Usefulness of segmented leads in anatomical variants
of the brain
Slotty P.1, Vesper J.1
1University Du¨sseldorf, Functional Neurosurgery and Stereotaxy,
Du¨sseldorf, Germany
Introduction: DBS is well known to be effective for suppressing
various movement disorders. Both primary and secondary dystonia
are improved by DBS. Potential limits due to side effects, may occur
especially in the proximity of internal capsule. Recently segmented
leads where introduced to reduce side effects and more efficiently
stimulate in the desired direction within the target area. We hereby
report on the first case of dystonia which was treated with those
directional segmented leads.
Methods: A 31-year-old female was suffering from generalized
dystonia for more than 20 years. Potentially symptoms were caused
by an ataxia with isolated Vitamin E deficiency syndrome. She
underwent DBS surgery using direct targeting of the left GPI. Stan-
dard coordinates did not match the individual anatomy of the patient
with distortion of the basal ganglia left and a hyperplastic posterior
horn of the lateral ventricle. Patient was completely wheelchair
bounded and suffered from severe dysarthria.
Results: After calculating standard coordinates (3.5 ant, 22 lateral and
4.0 below MCP), trajectory was adapted visually to the lateral border of
the optic tract. The posterior communicating artery which atypically
went over the optical tract was further limiting the approach. With 3
leads for MER surgery was conducted and electrode (Vercise DBS,
BSCI) was placed. Conventional stimulation caused a fast additional
dysarthria and painful stimulation side effects. Directional stimulation
on the left site provided one segment anteriorly, 1 posterolateral and
one posteromedial. The segmented contacts were programmed with the
least intensity. After 3 months the patient is able to walk without
caregivers help. Dysarthria was also significantly improved.
Conclusion: Directional segmented leads offer new perspectives for
DBS while reducing side effects and energy consumption. Further
investigations are warranted to evaluate their impact for improving
outcome and in general facilitating surgery to increase the acceptance
of this promising procedure.
Treatment of cervical dystonia (CD) with BoNT:
volume measurements of M. obliquus capitis inferior
(OCI) in 56 patients with and 23 without torticaput
Stenner A.1, Reichel G.1, Jahn A.2
1Paracelsus Clinic, Movement disorders, Zwickau, Germany,
2Radiologic Praxis, Zwickau, Germany
The classification of CD in 4 categories was replaced in 2009 (Reichel
et al.) with a more subtle classification into 11 types (4 collis and
caput types and 3 shifts). Although a clear correlation between the
muscles involved and the clinical findings exists, this is not clear for
the OCI muscle, which often is increased in diameter in torticaput. To
investigate whether the OCI is dystonic or just being passively
squeezed by the rotation of the lower atlanto-axial joint by other
dystonic muscles, we measured left and right OCI volume differences
by CT in 56 torticaput and 23 nondystonic patients (statistics:
MATLAB by Max Doberenz). If the head is deflected in nondystonic
patients to one side, the ipsilateral OCI is compressed and is higher in
volume that on the other side (0.2–0.5 ccm). The mean difference
between both OCI volumes in 56 torticaput patients was
1.50 ± 0.88 ccm. If one subtracts the standard deviation value from
the nondystonic patients and allows for the standard deviation of the
measurements in OCI patients, and the volume difference is still
positive, the muscle is contracted, i.e., dystonic. This was the case in
25 of 38 patients. Deflection of the head gives a shortening and
thickening of the ipsilateral OCI in nondystonic patients. The volume
of the muscle does not change significantly. In patients with tortica-
put, the volume difference between the OCI is increased, obviously a
sign of a volume increase in the dystonic OCI. In detail: if the OCI
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ipsilateral to the side to which the head is deflected is 1.013 ccm or
larger than that on the other side, it is dystonically contracted.
The measurement of OCI volume in torticaput patients can
determine whether it is dystonically contracted. This was true in 62%
of our sample of patients with torticaput.
Assessment of patient preference and clinical need
for flexible injection intervals in incobotulinumtoxinA
treatment of cervical dystonia and blepharospasm
Truong D.1, Sethi K.D.2, Fezza J.3, Evidente V.G.H.4
1The Parkinson’s and Movement Disorder Institute, Fountain Valley,
CA, USA, 2Georgia Regents University, Augusta, GA, USA, 3Center
for Sight, Sarasota, FL, USA, 4Movement Disorders Center
of Arizona, Scottsdale, AZ, USA
Introduction: Botulinum toxin type A (BoNT-A) injections are indi-
cated for the treatment of cervical dystonia (CD) and blepharospasm.
Minimum injection intervals of 12 weeks are generally recommended
(C10 weeks in Europe for incobotulinumtoxinA), despite common
symptom recurrence between treatments. We investigated the medical
need for more flexibility in injection intervals.
Methods: We conducted surveys with patients who had completed C2
BoNT-A treatment cycles. Patients with CD were interviewed
7–12 weeks after their last BoNT-A injection; patients with ble-
pharospasm were interviewed immediately before re-injection. Survey
data were compared with data from clinical trials that allowed incobo-
tulinumtoxinA (Xeomin) treatments at flexible intervals (C6 weeks)
based on patient request and investigator-assessed clinical need.
Results and discussion: We surveyed 136 patients with CD and 141
with blepharospasm [mean (standard deviation; SD) disease duration
of 92.9 (86.2) and 138.7 (111.0) months, respectively]. The mean
(SD) treatment interval patients usually received was 14 (3.7) weeks
for patients with CD and 12.5 (3.3) weeks for patients with ble-
pharospasm. However, the majority of patients indicated a preference
for BoNT-A-treatment intervals B12 weeks (CD, 78.4%; ble-
pharospasm, 69.5%), and many patients would prefer intervals
B10 weeks (CD, 46.3%; blepharospasm, 43.4%). In clinical trials
allowing flexible intervals (based on patient request and investigator-
assessed clinical need), 44.9% of CD treatments and 44.9% of ble-
pharospasm treatments were administered after intervals\12 weeks.
Furthermore, 29.5% of CD treatments and 26.5% of blepharospasm
treatments were required after intervals \10 weeks. The overall
incidence of adverse events was comparable between injection
intervals\12 weeks and C12 weeks in both indications.
In conclusion, patient survey and clinical trial data indicate that many
patients with CD or blepharospasm have a preference and a medical
need for BoNT-A-treatment intervals shorter than the 12-week stan-
dard interval, and that treatment interval flexibility does not
compromise incobotulinumtoxinA tolerability.
Effect of Deep brain stimulation on sleep and pain
in dystonia patients
Vuletic V.1,2, Chudy D.3, Almahariq F.3
1University Hospital Dubrava, Department of Neurology, Zagreb,
Croatia, 2Faculty of Medicine, University of Rijeka, Rijeka, Croatia,
3University Hospital Dubrava, Department of Neurosurgery, Zagreb,
Croatia
Background: There is rather high frequency of sleep problems and
pain in dystonia patients. They are often neglected and untreated
but affect significantly quality of life. Our aim was to see the effect
of Deep brain stimulation (DBS) on sleep and pain in dystonia
patients.
Methods: We conducted investigation with anamnesis and treat-
ments’ data, Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS),
Pittsburgh Sleep Quality Index (PSQI), Visual Analogue Scale,
McGill questionnaire and Hospital Anxiety and Depression Scale
(HADS). The study involved 10 patients with generalized dystonia.
We did the basal testing before DBS and another investigation after
6 months. In addition, we try to see factors that were connected with
pain and sleep problems.
Results: Six months after DBS we observed significant
improvement measuring by BFMDRS score [from 55 to 15.2
(72.3%, p\ 0.05)] and decrease in frequency concerning sleep
problems (from 90 to 10% of patients) and pain (from 90 to 20%)
(p\ 0.05). We found that both symptoms were associated with
depression.
Conclusions: DBS, beside motor improvement, helps in relieving of
the pain and sleep problems in dystonia patients.
Multimodal physiotherapy as an add-on treatment
to botulinum neurotoxin therapy in patients
with cervical dystonia
Werner C.1, Derlien S.1, Witte O.W.2, Gu¨nther A.2, Smolenski U.C.1
1Universita¨tsklinikum Jena, Institut fu¨r Physiotherapie, Jena,
Germany, 2Universita¨tsklinik Jena, Hans-Berger-Klinik fu¨r
Neurologie, Jena, Germany
Introduction: Treatment of choice for cervical dystonia (CD) com-
prises a local injection of botulinum neurotoxin type A (BoNT-A).
Whether additional physiotherapy can achieve better results is not
clearly documented in the literature. The present study aims to show
possible effects of physiotherapy as an add-on treatment to therapy
with botulinum neurotoxin.
Methods: 18 Patients with CD were enrolled in a prospective single-
center interventional study. Study duration comprised 6 months and
was divided into two phases with each phase lasting for 3 months.
First phase contained the usual BoNT-A application. Second phase
comprised a multimodal physiotherapy program consisting of two
45 min sessions per week in addition to the BoNT-A treatment. Pri-
mary outcome measures were quality of life using the SF-36 score
and the range of motion (ROM) determined by an ultrasonic based
measurement system (ZEBRIS). Secondary outcome measures
included the Toronto Western Spasmodic Torticollis Rating Scale
(TWSTRS) and electrical activity from the trapezius and the stern-
ocleidomastoid muscles measured by a surface electromyography
(EMG).
Results and discussion: In the pre-post comparison patients
showed significant improvements in the ROM (flexion/extension:
99.7 vs. 114.8; rotation: 105.5 vs. 123.6; lateral flexion: 56.6 vs.
70.9), physical health (SF-36 Score: 45.9 vs. 50.3) and TWSTRS-
Scores (severity: 14.1 vs. 11.3; disability: 5.7 vs. 4.4; pain: 6.9
vs. 3.6). There was no significant improvement in patient’s
mental health and there were no significant changes in the EMG
values.
In conclusion multimodal physiotherapy is a feasible and save addi-
tional treatment option for patients with cervical dystonia. An add-on
physiotherapy program can achieve better treatment outcomes.
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Especially in range of motion, severity and pain patients benefited
from the physiotherapy sessions.
What do medical students know about deep brain
stimulation?
Wloch A.1, Lu¨tjens G.1, Heissler H.1, Capelle H.H.1, Schrader C.2,
Krauss J.K.1
1Hannover Medical School, Department of Neurosurgery, Hannover,
Germany, 2Hannover Medical School, Department of Neurology,
Hannover, Germany
Objective: DBS is a well-established therapy for movement dis-
orders such as dystonia, Parkinson’s disease (PD) and tremor and it
is currently under investigation as a therapeutic option in neu-
ropsychiatric disorders. Little is known about medical students’
knowledge of this powerful tool when they enter university and
what they learn about it during their medical formation. Thus, the
objective here is to evaluate the knowledge of medical students
about deep brain stimulation (DBS) at the beginning and at the end
of their medical education.
Methods: A 10-item questionnaire with open and closed questions
was designed. Questions addressed indications for DBS, its costs,
impact on parkinsonian symptoms, complications, battery life, pos-
sible targets and percentage of PD patients who might profit from
DBS. Students at Hannover Medical School were asked to complete
the questionnaire in the preclinical study period and in the next to last
year of the study.
Results: The group of ‘‘beginners’’ included 209 students (duration
of study: 3 months) and the ‘‘advanced’’ group 170 students (du-
ration of study: 48–72 months). Of all students 63.6% were female
and 36.4% were male. Age ranged between 17 and 46 years, mean
21.9 years in the first group and 25.1 years in the second. In the
first group 22.7% had heard about DBS in medical lectures earlier
and 15.7% had gained insight by television before. In comparison
98.76% had heard of DBS in medical lectures in the second group
and knowledge was enhanced by television with 55.2%. In group
one 63.4% of the students knew that DBS is routinely used in PD
patients as compared to 83.3% in the second group. Knowledge
about other movement disorders was much less common. In the
first group only 36.6% knew that DBS is a routinely used treatment
for tremor, and only 10.3% knew that DBS is used in patients with
dystonia, whereas 71.5% of students in the second group knew
about the routine use of DBS in tremor but only one-third knew
about its use in dystonia (34%). Outcome after DBS, its costs, the
frequency of side effects, and established and future targets were
nearly unknown.
Conclusions: DBS is partly known among medical students in the
preclinical phase with a moderate gain of knowledge during further
study. We advocate to teach students more specifically and to expand
clinical knowledge during the clinical phase of medical studies. Ref.-
Nr. 162-544685059-761.
Complications of deep brain stimulation for secondary
dystonia in the early postoperative period (30-day
morbidity): an experience in 49 patients
Wloch A.1, Abdallat M.1, Saryyeva A.1, Blahak C.2, Wolf J.3,
Schrader C.4, Runge J.1, Krauss J.K.1
1Hannover Medical School, Department of Neurosurgery, Hannover,
Germany, 2UMM, Universita¨tsMedizin Mannheim, University
of Heidelberg, Department of Neurology, Mannheim, Germany,
3Diakonissenkrankenhaus, Department of Neurology, Mannheim,
Germany, 4Hannover Medical School, Department of Neurology,
Hannover, Germany
Objective: Deep brain stimulation (DBS) has been shown to be effi-
cacious in the treatment of primary dystonia. There is less experience in
secondary dystonia. Since patients with secondary dystonia, who are
often more disabled, may be more vulnerable to postoperative compli-
cations we aimed to investigate the 30-day morbidity in a large cohort of
patients with secondary dystonia operated over a period of 19 years.
Methods: From 1997 until 2016, a total of 49 patients [27 women and
22 men; mean age 43.5 years (range 13–77)] with secondary dystonia
underwent DBS with electrodes implanted either in the Thalamus or
the posteroventral lateral globus pallidus internus (GPi). Most fre-
quent cause of for dystonia was cerebral palsy in 17 patients.
Results: There were no intraoperative or directly postoperative
complications related to surgery. The electrode location was corrected
in 2 instances. Two patients developed a wound infection, one patient
had subdural hematoma and subcutaneous collection of cerebrospinal
fluid (CSF) 3 weeks after DBS a subdural hematoma and subcuta-
neous collection of cerebrospinal fluid (CSF).
Conclusion: The 30-day morbidity rate in DBS for secondary dys-
tonia is comparable to that in primary dystonia.
Long term follow-up in Mohr-Tranebjaerg syndrome
after pallidal stimulation
Wloch A.1, Blahak C.2, Ba¨zner H.3, Krauss J.K.1
1Hannover Medical School, Department of Neurosurgery, Hannover,
Germany, 2UMM, Universita¨tsMedizin Mannheim, University
of Heidelberg, Department of Neurology, Mannheim, Germany,
3Klinikum Stuttgart, Department of Neurology, Stuttgart, Germany
Objective: Pallidal deep brain stimulation (DBS) has been established
as a treatment option in patients with medically refractory dystonia.
Mohr-Tranebjaerg syndrome (MTS) or Dystonia-Deafness-Syndrome is
a rare genetic disorder characterized by deafness, dystonia and neuro-
logical abnormalities like impaired vision, dementia and cortical
blindness. So far little is known about the efficacy of DBS in MTS.
Methods: A 44-year-old man with a history of generalized dystonia,
deafness, visual blindness, ataxia and tremor was diagnosed with
MTS which was confirmed by genetic analysis. He underwent bilat-
eral stereotactic implantation of DBS electrodes in the posteroventral
lateral globus pallidus internus (GPi). Electrode location was con-
firmed by postoperative stereotactic CT.
Results: Bilateral pallidal stimulation yielded modest improvement
of dystonia at 6-months follow-up. During the next 4 months there
was an increase of tremor and ataxia. The initial benefit was lost
within the next 2 years. Extensive reprogramming did not yield
additional improvement. After 3 years of chronic stimulation it was
decided to switch off the pacemaker because of loss of efficacy.
Hyperkinesias after long term pallidal stimulation
for dystonia
Wloch A.1, Lu¨tjens G.1, Schrader C.2, Manu M.1, Blahak C.3
Abstracts 1525
123
1Hannover Medical School, Department of Neurosurgery, Hannover,
Germany, 2Hannover Medical School, Department of Neurology,
Hannover, Germany, 3UMM, Universita¨tsMedizin Mannheim,
University of Heidelberg, Department of Neurology, Mannheim,
Germany
Objective: The globus pallidus internus (GPi) is regarded as an
established and safe target for deep brain stimulation (DBS) in dys-
tonia. Recent reports on the occurrence of bradykinetic symptoms like
freezing, postural instability and micrographia after chronic DBS of
the GPi in patients with dystonia however stimulated a discussion on
alternative targets. Here, we report on the unusual occurrence of
dyskinesias upon chronic pallidal stimulation.
Methods: A 74-year-old man with segmental dystonia including
blepharospasm, orofacial dystonia and aerophagia underwent bilateral
stereotactic implantation of DBS electrodes in the GPi. Eleven years
later during effective chronic DBS for dystonia he experienced
gradual onset of hyperkinetic involuntary movements mainly con-
cerning his arms but also his trunk.
Results: Detailed assessment in various conditions showed that off DBS
resulted in an increase of both choreatic hyperkinesias and dystonia.
High frequency and low amplitude DBS improved both dystonia and
hyperkinesias, while high voltage DBS resulted in further improvement
of dystonia but also in increased hyperkinesias. As a compromise
between optimal stimulation for dystonia and hyperkinesias we finally
choose a bipolar intermediate amplitude stimulation mode.
Conclusion: Chronic pallidal DBS might be accompanied not only by
bradykinetic symptoms but also in the rare case by hyperkinesias. Such an
occurrence requires complex reassessment of stimulation programming.
Combined pallidal and thalamic stimulation
as a therapy option for multifocal primary dystonia
with prominent writers’ cramp
Wloch A.1, Abdallat M.1, Lu¨tjens G.1, Schrader C.1, Krauss J.K.1
1Hannover Medical School, Departments of Neurosurgery
and Neurology, Hannover, Germany
Objective: The globus pallidus internus (GPi) has been established as
the contemporary target of choice for deep brain stimulation (DBS) in
dystonia. The thalamic Vim, however, has been preferred in patients
with writer’s cramp. When a patient presents with both writer’s cramp
and other dystonic symptoms, it is unclear which target should be
chosen. Multifocal DBS is a new treatment option which can address
this issue.
Methods: A 23-year- old woman with multifocal primary dystonia
and prominent writers’ cramp underwent bilateral stereotactic
implantation of DBS electrodes in the GPi and the thalamic Vim.
Electrode location was confirmed by postoperative stereotactic CT.
All four electrodes were connected to an implantable pulse generator.
Assessment included the Burke-Fahn- Marsden Dystonia Rating
Scale (BFMDRS) motor and disability subscore, 36-item short-form
health score (SF-36) and standard video recording. In the frame of a
prospective study protocol clinical outcome was assessed before and
at 3, 15 and 24 months after surgery.
Results: Thalamic stimulation yielded an improvement in writer’s
cramp of about 80% according to the BFMDRS subscores. At
3 months follow-up the BFMDRS motor subscore had decreased from
3 before surgery to 0 and the disability subscore had decreased from 6
to 2. At the same time the SF-36 had improved from 31 to 78. The
effect lasted for 1 year. At 15 months follow-up the BFM motor
subscore had increased to 10 and the disability subscore had increased
to 6. The SF-36 had decreased to 67. The patient presented with an
increase in dystonia of the right hand and the right foot accompanied
by pain. Using bilateral and monopolar Vim thalamic stimulation did
not have a marked impact in the severity of dystonia. Bilateral GPi
stimulation alone improved slightly the dystonic symptoms in the
right foot but did not address the writer’s cramp. Because the patient
suffered in particularly right-sided dystonia a combined contralateral
thalamic and pallidal stimulation was chosen. We saw an improve-
ment almost immediately of both the writer’s cramp and the dystonic
foot after the initiation of the combined unilateral bipolar stimulation.
The BFM motor subscore had decreased to 6, the disability subscore
had decreased to 4 and SF-36 remained unchanged with 65. The effect
was sustained at 24 month follow-up. The combination of pallidal and
thalamic stimulation provided finally an improvement of 40% in BFM
motor subscore.
Conclusion: Combined thalamic and pallidal stimulation in patients
with multifocal primary dystonia under certain circumstances might
be an emergent therapy option.
Stable symptom improvement after battery depletion
in a patient with deep brain stimulation for secondary
dystonia
Wolf, Marc1; Blahak, Christian1; Schrader, Christoph2; Krauss,
Joachim3
1Universitaets Medizin Mannheim, University of Heidelberg,
Department of Neurology, Mannheim, Germany, 2Medical School
Hannover, Department of Neurology, Hannover, Germany, 3Medical
School Hannover, Department of Neurosurgery, Hannover, Germany
Background: In long-term studies, sustained clinical benefit of DBS
in dystonia has been reported. To maintain this effect, patients need
regularly replacements of the implantable pulse generator (IPG)
generally performed before complete battery depletion to avoid
temporary deterioration of dystonic symptoms.
Case report: At the age of 25, a male patient with generalized
secondary dystonia and choreatiform movements due to perinatal
asphyxia underwent bilateral DBS of the ventral intermediate
nucleus (Vim) of the thalamus and the posteroventral lateral globus
pallidus internus (GPi). Initially IPG was connected to Vim-DBS
electrodes. Preoperative clinical examination showed an action-
induced myocloniform tremor and dystonia with additional spastic
tetraparesis and ataxic gait, requiring a wheelchair for longer
distances. The patient was not able to drink from a glass by himself
and needed assistance for eating (BFM 80.5). Post-operatively,
dystonic tremor of the upper extremities clearly improved (BFM
67.5). Fourty months postoperatively the patient reported slowly
progressing dystonic symptoms, while the IPG revealed to be
switched-off since several months. Stimulation was changed to GPi
at IPG replacement leading to a noticeable improvement of gait
with continuing good control of dystonic tremor. At 76 months
after DBS implantation, the patient presented for his routine fol-
low-up with stable clinical symptoms, whereas DBS again revealed
to be switched off since 5 weeks.
Conclusions: In 2 studies that systematically analysed the re-oc-
currence of dystonic symptoms 24/48 h following DBS cessation,
dystonia did not reach the preoperative severity but remained at an
intermediate level in the majority of patients. All had DBS for
several years. Our patient had an extremely sustained clinical
benefit exceeding earlier expectations following DBS discontinu-
ation. He had DBS for many years and was sequentially stimulated
at two different sites, both of these aspects might play a role for
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persisting modulatory effect on the motor network following DBS
cessation.
Problems of the quality of life in patients with tardive
dyskinesia
Zakharov D.1, Khublarova L.1
1Federal State Budgetary Institution ‘‘Bekhterev Psychoneurological
Research Institute in St. Petersburg’’, Saint-Petersburg, Russian
Federation
Involuntary movements that develop on the background of drug
therapy can cause serious psychosocial consequences in patients.
Thus, these patients find it difficult not only because of their disease,
but also because of the poor orientation of the society to the disease.
The latter causes a constant feeling of shame, guilt, anxiety, and
anger, and leads to reduced quality of life.
The objective of this study was to evaluate the quality of life in
patients with neuroleptic complications.
Materials and methods: The study conducted on the basis of our site
involved 40 subjects (28 women, 12 men, aged from 23 to 76 years)
with verified diagnosis of ‘‘schizophrenia’’ in the state of remission
according to the ICD-10, with signs of late complications and
receiving neuroleptic antipsychotics for 12–216 months. Control
group involved 30 subjects with verified diagnosis of ‘‘schizophrenia’’
without tardive dyskinesia. The quality of life was assessed using the
SF-36 questionnaire.
Results: We have convincingly shown that these patients with
dyskinesia have a significant reduction in the quality of life compared
with the control group.
Conclusions: All of the above points complicate the course of the
underlying disease, increasing the severity of the negative and
affective disorders. These involuntary movements and mental illness
cause a marked reduction of quality of life.
This points to the obvious relevance of studying the problem and the
need to find new successful methods for correction of neuroleptic
complications.
Botulinum therapy offered for the patients with tardive
form of neuroleptic dyskinesia
Zakharov D.1, Khublarova L.1, Mikhaylov V.1
1St. Petersburg Bekhterev Psychoneurological Research Institute,
Saint-Petersburg, Russian Federation
Tardive neuroleptic dystonia is one of the most severe forms of
medical dyskinesias with poor response to the treatment. The severity
of neuroleptic side effects for patient often leads to a poor compli-
ance, which, in turn, often provokes an exacerbation of the
endogenous process.
The aim of this work is to study the effectiveness of botulinum
therapy with patients with tardive form of neuroleptic dyskinesia.
Materials and methods: 40 patients were included in the study group
with tardive neuroleptic complications, receiving neuroleptic
antipsychotics during 18–216 months. All the patients had tardive
neuroleptic complications appeared with dyskinesias predominantly
in the facial or neck muscles. All the patients received botulinum
toxin type A (Xeomin) which dose was individually selected from 70
to 300 ED.
Results: After the botulinum toxin treatment, all the patients noticed
positive dynamics of their condition. According to the Clinical Global
Impression rating scale treatment results were predominantly rated as
good and very good. Moreover, the results of Simpson scale showed a
decrease from 78.6 to 59.6; according to Simpson Angus rating scale
for extrapyramidal side effects there was a decrease with the total
score from 7.3 to 5.2. The same results we observed through
Abnormal Involuntary Movement Scale (AIMS) that suggested a
decrease with total score from 21.1 to 13.5. The patients with cervical
dystonia demonstrated maximum improvement. Minimum clinical
improvement was observed with elderly patients, the people suffering
from dyskinesia with incomplete dentition, or the lack of it. It should
be mentioned that unsatisfactory effect observed among the patients
with severe hyperkinesis of the tongue, which is obviously caused by
technical complexity of the injection as well.
Conclusions: All in all, the botulinum therapy seems to be one of the
most effective methods of the present time, to treat tardive neuroleptic
dyskinesias.
Dopamine, reversal learning and decision making:
Enhanced cognitive control in task-specific dystonia
Zeuner K.1, Knutzen A.1, Granert O.1, Sablowsky S.1, Dressler D.2,
Klein C.3, Witt K.1
1University of Kiel, Department of Neurology, Kiel, Germany,
2Movement Disorders Section, Department of Neurology, Hannover
Medical School, Hannover, Germany, 3Institute of Neurogenetics,
University of Lu¨beck, Lu¨beck, Germany
Background: In task specific dystonia previous receptor binding
studies suggest that dopamine signaling within the basal ganglia
circuits is abnormal. Furthermore, the DRD2/ANKK1-TaqIa poly-
morphism is associated with 30% reduction of the striatal dopamine
receptor density with reward-based learning and is impaired in
A ? subjects.
Method: Reward-based learning was compared between 31 writer’s
cramp patients and 35 controls using fMRI. Subjects chose in a
probabilistic reversal-learning task between two stimuli and indicated
their response with their left/right index finger. At first, one stimulus
response was rewarded in 80% (smiling face). A sad face was pre-
sented in 20% for the second stimulus. After 14–18 blocks the
contingencies reversed, and the second stimulus response was
rewarded in 80%. We further linked the DRD2/ANKK1-TaqIa
polymorphism.
Results: Feedback learning in patients was normal. Patients showed
greater increase in blood-oxygen level dependent (BOLD) signal
activity following negative feedback in the middle anterior cingulate
cortex (BA 32). The genetic status was not correlated with the BOLD
activity.
Conclusion: Brodmann area 32 (BA32) has an important role in
reward-based learning and is connected with the basal ganglia-tha-
lamo-loop modulated by dopaminergic signalling. This finding
suggests disturbed integration of reinforcement history when dopa-
mine is implicated in decision making. The results provide evidence
for a paradigm implicating dysfunction in the prefrontal cortex in task
specific dystonia.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (
http://creativecommons.org/licenses/by/4.0/), which permits unrest-
ricted use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if
changes were made.
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